Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Abacavir or its saltsPDL I DEC / 13
AbataceptPDL I DEC / 13
AbciximabPDL I DEC / 13
Abemaciclib or its saltsPDL I JUL / 19
Abiraterone or its derivativesPDL

including but not limited to abiraterone acetate

I DEC / 13
Acamprosate or its saltsPDL I DEC / 13
Acarbose or its derivativesPDL I DEC / 13
Acebutolol or its saltsPDL I DEC / 13
Acepromazine or its saltsPDL

for human use

I DEC / 13
AcetaminophenPDL

when recommended for administration by intravenous injection

I DEC / 13
Acetaminophen in sustained release formulations

up to and including 650 mg per unit, in package sizes containing no more than 50 units

U JAN / 03
Acetaminophen in sustained release formulations.

in strengths of greater than 650 mg per unit or in package sizes of more than 50 units

III JAN / 03
Acetaminophen. in immediate release tablets, capsules, suppositories or liquid U SEP / 99
AcetanilidePDL

for human use

I DEC / 13
Acetarsol II SEP / 98
AcetazolamidePDL I DEC / 13
AcetohexamidePDL I DEC / 13
AcetorphineN I JUN / 02
Acetyl-a-methylfentanylN I JUN / 02
AcetylcarbromalPDL I DEC / 13
Acetylcholine ChloridePDL I DEC / 13
Acetylcysteine II SEP / 98
AcetyldihydrocodeineN I JUN / 02
AcetylmethadolN I JUN / 02
Acetylsalicylic acid and its salts oral preparations containing 80 mg or less per dosage unit and intended for pediatric use or rectal preparations containing 150 mg or less per dosage unit, in package sizes containing no more than 1.92 g of acetylsalicylic acid. II FEB / 02
Acetylsalicylic acid and its salts. in products for oral use in strengths of 325mg and 500mg per dosage unit U OCT / 00
Acetylsalicylic acid and its salts.. in products intended for oral adult use in strengths of 81 mg per dosage unit and 650 mg or greater per dosage unit, and in rectal preparations containing more than 150 mg per dosage unit III OCT / 00
Acitretin or its salts or derivativesPDL I DEC / 13
Aclidinium or its saltsPDL I DEC / 13
Aconiazide or its saltsPDL I DEC / 13
Acyclovir or its saltsPDL I DEC / 13
AdalimumabPDL I DEC / 13
Adapalene or its salts or derivativesPDL I DEC / 13
Adefovir or its salts or derivativesPDL

including but not limited to adefovir dipivoxil

I DEC / 13
Adenosine or its saltsPDL

when sold or recommended for administration by intravenous injection

I DEC / 13
Adiphene and its salts for parenteral use II SEP / 98
Adrenocortical hormones or their salts or derivativesPDL

for human use including but not limited to: Betamethasone valerate, betamethasone sodium, betamethasone phosphate, betamethasone dipropionate, budesonide, ciclesonide, clobetasone, cortisone, dexamethasone sodium, dexamethasone phosphate, dexamethasone acetate, difluprednate, fludrocortisone acetate, flunisolide, fluticasone propionate, fluticasone furoate, hydrocortisone acetate, hydrocortisone aceponate, hydrocortisone sodium, methylprednisolone acetate, methylprednisolone, methylprednisolone succinate, methylprednisolone sodium, mometasone furoate, prednisolone acetate, prednisolone sodium, prednisolone phosphate, prednisone, triamcinolone acetonide, triamcinolone hexacetonide except: (a) hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 1.0% or less hydrocortisone in preparations for topical use on the skin; or (b) hydrocortisone or hydrocortisone acetate, when sold in combination with any other nonprescription medicinal ingredient that provides 1.0% or less hydrocortisone in preparations for topical use on the skin; or (c) clobetasone butyrate when sold in a concentration of 0.05% in cream preparations for topical use on the skin; or (d) triamcinolone acetonide in a nasal spray that delivers 55 microgram (mcg)/spray for those 12 years of age and older; or, (e) mometasone furoate for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 12 years of age and older; or (f) fluticasone propionate for the treatment of allergic rhinitis in a nasal spray that delivers 50 microgram/spray for those 18 years of age and older.

I AUG / 16
Afatinib or its saltsPDL I DEC / 13
AfliberceptPDL I DEC / 13
AfoxolanerPDL I AUG / 14
Agalsidase AlfaPDL I APR / 07
Agalsidase BetaPDL I DEC / 14
AlbiglutidePDL I AUG / 15
AldesleukinPDL I DEC / 13
Alectinib or its saltsPDL I NOV / 16
AlefaceptPDL I DEC / 13
AlemtuzumabPDL I DEC / 13
Alendronic acid or its saltsPDL I DEC / 13
AlfacalcidolPDL I DEC / 13
AlfentanilN I JUN / 02
Alfuzosin or its saltsPDL I DEC / 13
Alglucosidase alfaPDL I DEC / 13
AlirocumabPDL I AUG / 16
Aliskiren or its saltsPDL I DEC / 13
Alitretinoin or its salts or derivativesPDL I DEC / 13
Alkyl nitritesPDL I DEC / 13
Allergy serums and extracts I SEP / 99
Allethrins II SEP / 98
AllobarbitalC2 I JUN / 02
AllopurinolPDL I DEC / 13
AllylisopropylacetylureaPDL I DEC / 13
AllylprodineN I JUN / 02
Almotriptan or its saltsPDL I DEC / 13
Aloe vera latex, its extracts and derivatives[except aloin] dosage forms for systemic use containing more than 300 mg per dosage unit III SEP / 98
Alogliptin or its salts or its derivativesPDL I DEC / 13
Aloin U
Alpha-chloralosePDL I DEC / 13
Alpha-hydroxy acidsPDL

including but not limited to citric acid, glycolic acid, lactic acid, malic acid, mandelic acid, ammonium glycolate, glycolic acid + ammonium glycolate, alpha-hydroxyethanoic acid + ammonium alpha-hydroxyethanoate, alpha-hydroxyoctanoic acid, alpha-hydroxycaprylic acid, hydroxycaprylic acid, mixed fruit acid, triple fruit acid, tri-alpha hydroxy fruit acids, alpha hydroxy and botanical complex, l-alpha hydroxy acid, glycomer in cross-linked fatty acids alpha nutrium, when sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations of greater than 30% and/or with a pH lower than 3.0, except when sold to be applied to warts, corns or calluses

I DEC / 14
AlphacetylmethadolN I JUN / 02
Alphadolone or its saltsPDL I DEC / 13
AlphameprodineN I JUN / 02
AlphamethadolN I JUN / 02
AlphaprodineN I JUN / 02
AlphaxalonePDL

including but not limited to alfaxalone, alphaxolone

I DEC / 13
AlphenalC2 I JUN / 02
AlprazolamTS I SEP / 98
Alteplase or its salts or derivativesPDL

including but not limited to tenecteplase

I DEC / 13
AltrenogestPDL I DEC / 13
AltretaminePDL I DEC / 13
Aluminum oxide III SEP / 98
Alverine and its salts for parenteral use I SEP / 98
Amantadine or its saltsPDL I DEC / 13
Ambenonium ChloridePDL I DEC / 13
AmbrisentanPDL I DEC / 13
Amifostine or its saltsPDL I DEC / 13
Amikacin or its salts or derivativesPDL

PDL, including but not limited to amikacin sulfate

I DEC / 13
Amiloride or its saltsPDL I DEC / 13
Amino Acid solutions for parenteral use I SEP / 99
Amino-pteroyl aspartic acid or its saltsPDL I DEC / 13
Aminocaproic acidPDL I DEC / 13
AminoglutethimidePDL I DEC / 13
Aminolevulinic acid or its salts or derivativesPDL I DEC / 13
AminophyllinePDL I DEC / 13
Aminopromazine [proquamezine] and its salts I SEP / 98
Aminopterin or its salts or derivativesPDL I DEC / 13
Aminopyrine or its derivativesPDL

for human use

I DEC / 13
AminorexC1

(5-phenyl-4, 5-dihydro-1, 3-oxazol-2-amine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including 4-Methylaminorex (4-methyl-5-phenyl-4, 5-dihydro-1, 3-oxazol-2-amine) and 4,4'-Dimethylaminorex (4-methyl-5-(4-methylphenyl)-4, 5-dihydro-1, 3-oxazol-2-amine)

I DEC / 17
Aminosalicylic Acid or its saltsPDL I DEC / 13
Aminosalicylic acidPDL

including but not limited to mesalazine

I DEC / 13
Amiodarone or its salts or derivativesPDL

including but not limited to dronedarone

I DEC / 13
AmitrazPDL I DEC / 13
Amitriptyline or its saltsPDL I DEC / 13
Amlexanox or its salts or derivativesPDL I DEC / 13
Amlodipine or its saltsPDL I DEC / 13
Ammonium bromidePDL I DEC / 13
Ammonium hydroxide U
AmobarbitalC2 I JUN / 02
AmoxapinePDL I DEC / 13
AmphetamineC1 I JUN / 02
Amphotericin B or its salts or derivativesPDL I DEC / 13
Amprenavir or its salts or derivatives

including but not limited to fosamprenavir

I DEC / 13
Amprolium or its saltsPDL

for human use

I DEC / 13
Amrinone or its saltsPDL I DEC / 13
Amsacrine or its saltsPDL I DEC / 13
Amylocaine and its salts in preparations for topical use on mucous membranes except lozenges III SEP / 98
Amylocaine and its salts for ophthalmic or parenteral use II SEP / 98
Anagrelide or its saltsPDL I DEC / 13
Anakinra or its salts or derivativesPDL I DEC / 13
AnastrozolePDL I DEC / 13
AncestimPDL I DEC / 13
AndroisoxazoleC3 I JUN / 02
AndrostanoloneC3 I JUN / 02
AndrostenediolC3 I JUN / 02
Anetholtrithione III SEP / 98
AnidulafunginPDL I DEC / 13
AnileridineN I JUN / 02
Anisotropine and its salts II SEP / 98
Antazoline and its salts III SEP / 98
Anthralin II SEP / 98
Anti-thymocyte globulinPDL I DEC / 13
Antihemophilic factor, human II SEP / 98
AntipyrinePDL

for human use, except preparations for topical use

I DEC / 13
Antipyrine.

except otic preparations

II SEP / 98
Antipyrine..

for otic use

III SEP / 98
Apalutamide or its saltsPDL I JUL / 18
Apixaban or its derivativesPDL I DEC / 13
Apomorphine or its saltsPDL I FEB / 17
Apraclonidine or its saltsPDL I DEC / 13
Apramycin or its saltsPDL I DEC / 18
ApremilastPDL I DEC / 14
Aprepitant or its derivativesPDL

including but not limited to fosaprepitant

I DEC / 13
AprobarbitalC2 I JUN / 02
AprotininPDL I DEC / 13
Argatroban or its salts or derivativesPDL I DEC / 13
Arginine and its salts II SEP / 98
Aripiprazole or its saltsPDL I DEC / 13
Arsenic trioxidePDL I DEC / 13
Artemisia, its preparations, extracts and compounds except in trace amounts in homeopathic preparations II SEP / 98
Asenapine or its salts or derivativesPDL

including but not limited to asenapine maleate

I DEC / 13
Asfotase alfaPDL I OCT / 15
AsparaginasePDL

when sold for administration by injection

I DEC / 13
Astemizole or its saltsPDL I DEC / 13
AsunaprevirPDL I AUG / 16
Atazanavir or its saltsPDL I DEC / 13
Atenolol or its saltsPDL I DEC / 13
AtezolizumabPDL I MAY / 17
Atipamezole or its satlsPDL I DEC / 13
Atomoxetine or its saltsPDL I DEC / 13
Atorvastatin or its saltsPDL I DEC / 13
AtovaquonePDL I DEC / 13
Atracurium besilatePDL I DEC / 13
Atropine or its saltsPDL

including but not limited to atropine sulphate, in ophthalmic or parenteral preparations

I DEC / 13
Attapulgite active U
AvelumabPDL I MAR / 18
Avermectin or its derivativesPDL

including but not limited to ivermectin, selamectin, doramectin for human use

I DEC / 13
Avermectin or its derivatives.F1

For veterinary use, including but no limited to ivermectin when recommended for intramuscular injection for horses or for oral.

I MAY / 04
Avilamycin or its salts or derivativesPDL I MAR / 14
Axicabtagene ciloleucelPDL I MAR / 19
Axitinib or its salts or derivativesPDL I DEC / 13
Azacitidine or its salts or derivativesPDL I DEC / 13
Azacyclonol or its saltsPDL I DEC / 13
AzaribinePDL I DEC / 13
Azathioprine or its saltsPDL I DEC / 13
Azatidine or its saltsPDL

including but not limited to azatadine

I DEC / 13
Azelaic acidPDL I DEC / 13
Azelastine or its saltsPDL I DEC / 14
Azilsartan medoxomil or its salts or derivativesPDL I DEC / 13
Aztreonam or its saltsPDL I DEC / 13
Bacillus Calmette-Guerin vaccine I FEB / 02
Bacitracin or its salts or derivativesPDL

For veterinary use

I DEC / 18
Bacitracin or its salts or derivatives .

For human use: for parenteral use

I SEP / 98
Bacitracin or its salts or derivatives ..

For human use: for topical use

U SEP / 98
Bacitracin or its salts or derivatives …

For human use: for ophthalmic use

III JUN / 06
Baclofen or its saltsPDL I DEC / 13
Bambuterol or its saltsPDL I DEC / 13
BarbitalC2 I JUN / 02
Barbituric AcidC2 I JUN / 02
Baricitinib or its saltsPDL I OCT / 18
BasiliximabPDL I DEC / 13
Bazedoxifene or its saltsPDL I DEC / 14
BecaplerminPDL I DEC / 13
BelimumabPDL I DEC / 13
Belladonna alkaloids and their salts and derivatives for topical use III SEP / 98
Belladonna alkaloids, and their salts and derivatives except in preparations for topical use or in trace amounts in homeopathic preparations II SEP / 98
BemegridePDL I DEC / 13
Benactyzine or its saltsPDL I DEC / 13
Benazepril or its salts or derivativesPDL

including but not limited to benazepril hydrochloride

I DEC / 13
Bendamustine or its salts or derivativesPDL

including but not limited to bendamustine hydrochloride

I DEC / 13
Bendazac or its saltsPDL I DEC / 13
Benoxaprofen or its saltsPDL I DEC / 13
Benoxinate hydrochloride oxybuprocaine for ophthalmic or parenteral use II SEP / 98
BenralizumabPDL I MAY / 18
Benserazide or its saltsPDL I DEC / 13
Bentiromide II SEP / 98
Benzalkonium and its salts liquid preparations in concentrations of more than 2% II SEP / 98
BenzethidineN I JUN / 02
Benzethonium chloride liquid preparations in concentrations of more than 1% II SEP / 98
Benzocaine and its salts for parenteral or ophthalmic use II SEP / 98
Benzocaine and its salts. for topical use on mucous membranes for teething III SEP / 98
Benzocaine and its salts.. for topical application on the skin U
Benzonatate III SEP / 98
Benzoyl peroxidePDL

in concentrations greater than 5% or when sold in combination with another medicinal ingredient

I DEC / 13
Benzoyl peroxide. preparations of 5% or less as a single ingredient U MAY / 08
BenzphetamineC1 I JUN / 02
Benztropine or its saltsPDL

including but not limited to benzatropine

I DEC / 13
Benzydamine or its saltsPDL I DEC / 13
Benzyl benzoate II SEP / 98
BenzylmorphineN I JUN / 02
Bepotastine or its salts or derivativesPDL I NOV / 16
BeractantPDL I DEC / 13
Berberis vulgaris Barberry III SEP / 98
Besifloxacin or its saltsPDL I DEC / 13
BetacetylmethadolN I JUN / 02
Betahistine or its saltsPDL I DEC / 13
Betaine or its saltsPDL

for human use, when sold or recommended for the treatment of homocystinuria

I DEC / 13
Betaine or its salts.

for veterinary use

I DEC / 13
BetameprodineN I JUN / 02
BetamethadolN I JUN / 02
BetaprodineN I JUN / 02
Betaxolol or its saltsPDL I DEC / 13
Bethanechol chloridePDL I DEC / 13
Bethanidine or its saltsPDL I DEC / 13
BevacizumabPDL I DEC / 13
Bezafibrate or its salts or derivativesPDL I DEC / 13
BicalutamidePDL I DEC / 13
Bictegravir or its saltsPDL I AUG / 18
Bilastine or its salts or derivativesPDL I AUG / 16
Bile salts U
Bioflavanoids U
Biperiden or its saltsPDL I DEC / 13
Bisacodyl when sold in concentrations of 5mg or less per oral dosage unit or 10mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50mg of bisacodyl U JAN / 14
Bisacodyl and its salts

(except when sold in concentrations of 5mg or less per oral dosage unit or 10mg or less per rectal dosage unit/suppository in package sizes containing no more than 50mg of bisacodyl)

III JAN / 14
Bishydroxycoumarin or its salts or derivativesPDL I DEC / 13
Bisoprolol or its saltsPDL I DEC / 13
Bitolterol or its saltsPDL I DEC / 13
BivalirudinPDL I DEC / 13
BleomycinPDL I DEC / 13
BlinatumomabPDL I AUG / 16
Boceprevir or its derivativesPDL I DEC / 13
BolandiolC3 I JUN / 02
BolasteroneC3 I JUN / 02
BolazineC3 I JUN / 02
BoldenoneC3 I JUN / 02
BolenolC3 I JUN / 02
Boric acid and its salts in preparations for systemic use, or ophthalmic preparations in concentrations over 2%[Note: does not apply to contact lens solutions intended to be rinsed off prior to insertion in the eye] II DEC / 98
Boric acid and its salts. in ophthalmic preparations in concentrations up to and including 2%, and in contact lens solutions intended to be rinsed off prior to insertion into the eye U DEC / 98
BortezomibPDL I DEC / 13
Bosentan or its salts or derivativesPDL I DEC / 13
Bosutinib or its saltsPDL

including but not limited to Bosutinib methanoate

I AUG / 14
Botulinum toxinPDL

including but not limited to onabotulinumtoxin A, incobotulinumtoxin A, abobotulinumtoxin A, rimabotulinumtoxin B, prabotulinumtoxin A

I DEC / 13
Brentuximab vedotinPDL I DEC / 13
Bretylium tosylatePDL I DEC / 13
Brexpiprazole or its saltsPDL I APR / 17
Brigatinib or its saltsPDL I AUG / 18
Brimonidine or its saltsPDL I DEC / 13
Brivaracetam or its derivativesPDL I AUG / 16
BrodalumabPDL I MAY / 18
BromalPDL I DEC / 13
Bromal hydratePDL I DEC / 13
Bromazepam and its saltsTS I SEP / 98
BrometonePDL I DEC / 13
Bromfenac or its saltsPDL I MAY / 15
BromisovalPDL I DEC / 13
Bromocriptine or its saltsPDL I DEC / 13
BromoformPDL I DEC / 13
Brompheniramine and its salts as a single entity for the treatment of allergies III JAN / 03
Brompheniramine and its salts. in combination products for the relief of cough and cold symptoms U JAN / 03
BrotizolamTS I JUN / 02
Buclizine II SEP / 98
Bufexamac II SEP / 98
Bumetanide or its salts or derivativesPDL I DEC / 13
Bupivacaine and its salts for topical use on mucous membranes except lozenges III SEP / 98
Bupivacaine and its salts for parenteral or ophthalmic use II SEP / 98
BuprenorphineN I JUN / 02
Bupropion or its saltsPDL I DEC / 13
BurosumabPDL I DEC / 18
Buserelin or its saltsPDL I DEC / 13
Buspirone or its saltsPDL I DEC / 13
BusulfanPDL I DEC / 13
ButabarbitalC2 I JUN / 02
Butacaine and its salts for ophthalmic or parenteral use II SEP / 98
ButalbitalC2 I JUN / 02
ButallylonalC2 I JUN / 02
Butaperazine or its saltsPDL I DEC / 13
Butenafine 1% cream U SEP / 99
ButethalC2 I JUN / 02
Butoconazole or its saltsPDL I DEC / 13
Butorphanol and any salt thereofC2 I JUN / 02
Butyl chloral hydratePDL I DEC / 13
Cabergoline or its saltsPDL I DEC / 13
Cabozantinib or its saltsPDL I NOV / 18
CalcifediolPDL I JUL / 18
CalcipotriolPDL I DEC / 13
CalcitoninPDL I DEC / 13
CalcitriolPDL I DEC / 13
Calcium bromidePDL I DEC / 13
Calcium bromolactobionatePDL I DEC / 13
Calcium carbimidePDL I DEC / 13
Calcium chloride in injectable form for parenteral nutrition I JAN / 03
Calcium disodium edetate II SEP / 98
Calcium gluconate in injectable form for parenteral nutrition I JAN / 03
Calcium polycarbophil III SEP / 98
Calcium salts when sold for the treatment of hyperphosphatemiaPDL I DEC / 13
CalusteroneC3 I JUN / 02
CamazepamTS I JUN / 02
Camphor in oleaginous vehicles and in liquid forms in concentrations greater than 11% II OCT / 98
Camphor. in oleaginous vehicles and in liquid forms in concentrations up to and including 11% U OCT / 98
CanagliflozinPDL I JUL / 14
CanakinumabPDL I DEC / 13
Candesartan or its salts or derivatives

including but not limited to candesartan cilexetil

I DEC / 13
Candicidin or its salts or derivativesPDL I DEC / 13
Cantharides, their preparations and derivatives II SEP / 98
Capreomycin or its salts ir deriviativesPDL I DEC / 13
Caprylic acid except when sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.0 for a use other than to be applied to warts, corns or calluses U DEC / 14
Capsaicin U AUG / 97
Captodiamine or its saltsPDL I DEC / 13
Captopril or its saltsPDL I DEC / 13
CarbacholPDL I DEC / 13
CarbamazepinePDL I DEC / 13
Carbapenem salts or derivativesPDL

Including but not limited to: Doripenem, ertapenem, imipenem, meropenem

I DEC / 18
Carbenoxolone or its saltsPDL I DEC / 13
Carbetocin or its saltsPDL I DEC / 13
Carbidopa or its saltsPDL I DEC / 13
CarbimazolePDL I DEC / 13
Carbinoxamine or its salts III SEP / 98
CarbocisteinePDL I DEC / 13
Carbomycin or its salts or derivativesPDL I DEC / 13
CarboplatinPDL I DEC / 13
CarbromalPDL I DEC / 13
CarfentanilN I JUN / 02
CarfilzomibPDL I AUG / 16
Carglumic acid or its salts or derivativesPDL I JUN / 15
CarisoprodolPDL I DEC / 13
CarmustinePDL I DEC / 13
Carphenazine or its saltsPDL I DEC / 13
Carprofen or its salts or derivativesPDL I DEC / 13
Carvedilol and its saltsPDL I DEC / 13
Casanthranol III SEP / 98
Cascara sagrada or its extracts or derivatives U AUG / 97
Caspofungin or its salts or derivativesPDL I DEC / 13
CatumaxomabPDL I DEC / 13
Celecoxib or its saltsPDL I DEC / 13
CemiplimabPDL I JUL / 19
CenegerminPDL I MAR / 19
Cephalosporin C or its salts or derivatives or analogsPDL

Including but not limited to: Cephalexin (cefalexin), cephapirin (cefapirin), cefaclor, cefadroxil, cefazolin, cefonicide, cefoxitin, cefprozil, cefuroxime, loracarbef, cefdinir, cefixime, cefoperazone, cefotaxime, cefpodoxime proxetil, ceftazidime, ceftibuten, ceftriaxone, cefepime, ceftobiprole, ceftolozane, cefovecin, ceftiofur

I DEC / 18
Cerapon III SEP / 98
Ceritinib or its saltsPDL I MAY / 15
Cerivastatin or its saltsPDL I DEC / 13
Cerliponase alfaPDL I FEB / 19
Certolizumab pegolPDL I DEC / 13
Cetirizine or its saltsPDL

see hydroxyzine or its salts or derivatives

I DEC / 13
Cetirizine or its salts. in concentrations of 10 mg equivalent to 8.5 mg or less of cetirizine base per dosage unit, in products marketed for pediatric use (under 12 years of age) III JUL / 02
Cetirizine or its salts..

in concentrations of 10mg equivalent to 8.5mg or less of cetirizine base per dosage unit) in products marketed for adult use (age 12 and over)

U JUL / 02
Cetrorelix or its saltsPDL I DEC / 13
CetuximabPDL I DEC / 13
Charcoal (activated) except for use in poisoning treatment U JUN / 98
Charcoal [activated] for use in poisoning treatment II SEP / 98
Chlophedianol and its salts III SEP / 98
ChloralPDL I DEC / 13
Chloral hydratePDL I DEC / 13
ChloralformamidePDL I DEC / 13
ChloralimidePDL I DEC / 13
Chlorambucil or its salts or derivativesPDL I DEC / 13
Chloramphenicol or its salts or derivativesPDL I DEC / 13
Chlorcyclizine or its saltsPDL

except in preparations for external use

I DEC / 13
Chlordiazepoxide and its saltsTS I SEP / 98
Chlorhexidine or its saltsPDL

for human use when used as a topical oral preparation

I DEC / 13
Chlorisondamine or its saltsPDL I DEC / 13
ChlormezanonePDL I DEC / 13
Chloroprocaine and its salts for parenteral or ophthalmic use II SEP / 98
Chloroprocaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Chloroquine or its saltsPDL I DEC / 13
Chlorothiazide or its salts or derivatives

for human use

I DEC / 13
Chlorpheniramine and its salts and preparations U AUG / 97
Chlorphentermine and any salt thereofC2 I JUN / 02
Chlorpromazine or its saltsPDL

for human use

I DEC / 13
ChlorpropamidePDL I DEC / 13
Chlorprothixene or its saltsPDL I DEC / 13
Chlortetracycline or its saltsPDL

For veterinary use

I DEC / 18
Chlorzoxazone and its salts III SEP / 98
Cholecystokinin II SEP / 98
Cholera vaccine except oral, inactivated, when used for prophylaxis against travellers' diarrhea & due to enterotoxigenic escherichia coli (ETEC) I JAN / 04
Cholera vaccine (oral, inactivated) when used for prophylaxis against travellers' diarrhea & due to enterotoxigenic escherichia coli (ETEC) II JAN / 04
Cholestyramine resinPDL

for human use

I DEC / 13
Choline bitartrate parenteral II SEP / 98
Choline salicylatePDL

when sold in combination with magnesium salicylate

I DEC / 13
Choline theophyllinatePDL I DEC / 13
Choriogonadotropin alfaPDL I DEC / 13
Chromium Chloride (chromic chloride) in injectable form for parenteral nutrition I JAN / 03
Chymopapain parenteral II SEP / 98
Chymotrypsin parenteral and ophthalmic II SEP / 98
Ciclopirox or its saltsPDL I DEC / 13
Cidofovir or its salts or its derivativesPDL I MAY / 18
Cilastatin or its saltsPDL I DEC / 13
Cilazapril or its salts or derivativesPDL I DEC / 13
Cimetidine or its saltsPDL

for veterinary use

I DEC / 13
Cimetidine or its salts.PDL

except when sold in concentrations of 200 milligrams or less per oral dosage unit and indicated for the treatment of heartburn

I DEC / 13
Cimetidine or its salts..

when sold in concentrations of 100 mg or less per dosage unit and indicated for the treatment of heartburn

III DEC / 13
Cinacalcet or its saltsPDL I DEC / 13
Cinchocaine (dibucaine) and its salts for ophthalmic or parenteral use II SEP / 98
Cinchophene or its saltsPDL I DEC / 13
Cinnamedrine U
CinoxacinPDL I DEC / 13
Ciprofloxacin or its saltsPDL I DEC / 13
Cisapride or its saltsPDL I SEP / 98
Cisatracurium besilatePDL I DEC / 13
CisplatinPDL I DEC / 13
Citalopram or its saltsPDL I DEC / 13
Cladribine or its salts or derivativesPDL I DEC / 13
Clemastine and its salts III SEP / 98
Clenbuterol or its saltsPDL I DEC / 13
Clevidipine or its saltsPDL I DEC / 13
Clidinium and its salts II SEP / 98
Clobazam and its saltsTS I SEP / 98
Clobetasone butyrate when sold in a concentration of 0.05% clobetasone butyrate in cream preparations for topical use on the skin II OCT / 06
Clodronic acid or its saltsPDL I DEC / 13
ClofarabinePDL I DEC / 13
ClofibratePDL I DEC / 13
Clomiphene or its saltsPDL I DEC / 13
Clomipramine or its saltsPDL I DEC / 13
Clonazepam and its saltsTS I SEP / 98
Clonidine or its saltsPDL I DEC / 13
ClonitazeneN I JUN / 02
Clopidogrel or its saltsPDL I DEC / 13
ClorazepateTS I JUN / 02
Clorazepic acid or its saltsPDL I DEC / 13
Closantel or its saltsPDL

for veterinary use, including but not limited to closantel sodium

I AUG / 16
ClostebolC3 I JUN / 02
Clotiazepam and any salt thereofTS I JUN / 02
Clotrimazole and its salts.. for human use in preparations for topical use U DEC / 13
Clotrimazole or its saltsPDL

for human use, except in preparations for topical or vaginal use

I DEC / 13
Clotrimazole or its salts.

for human use in preparations for intra-vaginal use

III DEC / 13
CloxazolamTS I JUN / 02
Clozapine or its saltsPDL I DEC / 13
Coal tar in concentrations of more than 10% II SEP / 98
Coal tar. in concentrations up to and including 10% U
Cobicistat or its saltsPDL I DEC / 18
Cobimetinib or its saltsPDL I AUG / 16
Coca leavesN I JUN / 02
Cocaine (benzoylmethylecgonine)N Subject to Section 2 (2) of the Narcotic Control Regulations (NCR) and Section J of the Food and Drug Regulations (FDR) as of 23 October 2013. I JUN / 02
CodeineN I JUN / 02
Codeine and its salts in preparations exempted from the Regulations to the Controlled Drugs and Substances Act II SEP / 98
CodoximeN I JUN / 02
ColchicinePDL I DEC / 13
Colesevelam or its saltsPDL

including but not limited to colesevelam hydrochloride

I DEC / 13
Colestipol or its saltsPDL I DEC / 13
Colfosceril or its derivativesPDL I DEC / 13
Colistin or its salt or derivativesPDL

including but not limited to colistimethate

I DEC / 13
CollagenasePDL

when recommend for the debridement of severe burns and skin ulcers

I DEC / 13
Copper chloride (cupric chloride) in injectable form for parenteral nutrition I JAN / 03
Copper sulfate in injectable form for parenteral nutrition I JAN / 03
CrisaborolePDL I JUL / 18
Crizotinib or its salts or derivativesPDL I DEC / 13
Cromoglicic (cromoglycic) acid or its saltsPDL

except sodium cromoglicate (cromoglycate) in solutions for ophthalmic or nasal use in concentrations of 2% or less [*see sodium cromoglicate (cromoglycate)]

I DEC / 13
Crotamiton II SEP / 98
Cyclandelate II SEP / 98
Cyclazocine and its salts II SEP / 98
CyclizinePDL

for human use

I DEC / 13
CyclobarbitalC2 I JUN / 02
Cyclobenzaprine or its saltsPDL I DEC / 13
Cyclomethacaine and its salts for ophthalmic or parenteral use II SEP / 98
CyclopalC2 I JUN / 02
Cyclopentamine and its salts II SEP / 98
Cyclopentolate or its salts except in products for ophthalmic or parenteral use II SEP / 98
Cyclopentolate or its saltsPDL

in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada

I DEC / 13
CyclophosphamidePDL I DEC / 13
CycloserinePDL I DEC / 13
CyclosporinePDL

including but not limited to ciclosporin

I DEC / 13
Cyproheptadine and its salts II SEP / 98
Cyproterone acetatePDL

including but not limited to cyproterone acetate

I DEC / 13
Cysteamine (Mercaptamine) or its saltsPDL I AUG / 17
Cytarabine or its saltsPDL I DEC / 13
Cytomegalovirus immune globulins I FEB / 02
Dabigatran or its salts or derivativesPDL

including but not limited to dabigatran etexilate

I DEC / 13
Dabrafenib or its saltsPDL I DEC / 13
DacarbazinePDL I DEC / 13
Daclatasvir or its saltsPDL I OCT / 15
DaclizumabPDL I DEC / 13
Daclizumab betaPDL I FEB / 17
Dacomitinib or its saltsPDL I MAR / 19
DactinomycinPDL I DEC / 13
Dalbavancin or its saltsPDL I OCT / 18
Dalfopristin or its saltsPDL I DEC / 13
Dalteparin or its saltsPDL I DEC / 13
Danaparoid or its salts or derivativesPDL I DEC / 13
DanazolPDL I DEC / 13
Danofloxacin or its saltsPDL I DEC / 13
Danthron III SEP / 98
Dantrolene or its saltsPDL I DEC / 13
Dapagliflozin or its derivativesPDL I MAR / 15
Dapiprazole or its saltsPDL I DEC / 13
DaptomycinPDL I DEC / 13
DaratumumabPDL I AUG / 16
Darifenacin or its saltsPDL I DEC / 13
DarunavirPDL I DEC / 13
Dasabuvir or its saltsPDL I MAR / 15
DasatanibPDL I DEC / 13
Daunorubicin or its saltsPDL I DEC / 13
Debrisoquin or its saltsPDL I DEC / 13
Decitabine or its saltsPDL I FEB / 19
DeferasiroxPDL I DEC / 13
Deferiprone or its derivativesPDL I MAR / 15
Deferoxamine or its saltsPDL I DEC / 13
Defibrotide or its salts or derivativesPDL I SEP / 17
Degarelix or its salts or derivativesPDL I DEC / 13
Dehydrocholic acid and its salts III SEP / 98
Delavirdine or its saltsPDL I DEC / 13
DelorazepamTS I JUN / 02
DenosumabPDL I DEC / 13
Deoxycholic acid or its saltsPDL

when used in an injectable form

I OCT / 15
Deoxycholic acid or its salts.

except when used in an injectable form

III OCT / 15
DeracoxibPDL I DEC / 13
Derquantel or its saltsPDL

for veterinary use

I AUG / 16
Deserpidine or its alkaloids or saltsPDL I DEC / 13
DesfluranePDL I DEC / 13
Desipramine or its saltsPDL I DEC / 13
Desloratadine and its salts and preparations. in products marketed for paediatric use - under 12 years of age III SEP / 05
Desloratadine and its salts and preparations.

in products marketed for adult use - 12 years and older

U SEP / 05
Desmopressin or its saltsPDL I DEC / 13
DesomorphineN I JUN / 02
Desoxyribonuclease [pancreatic dornase] II SEP / 98
Desvenlafaxine or its saltsPDL

including but not limited to desvenlafaxine succinate

I DEC / 13
Detomidine or its saltsPDL I DEC / 13
Dexbrompheniramine and its salts III SEP / 98
Dexchlorpheniramine and its salts III SEP / 98
Dexrazoxane or its saltsPDL I DEC / 13
Dextromethorphan and its salts except in oral dosage forms in package sizes containing no more than 300mg DM base or 409.3 DM hydrobromide III AUG / 02
Dextromethorphan and its salts. in oral dosage forms in package sizes containing no more than 300 mg DM base or 409.3 DM hydrobromide U AUG / 02
DextromoramideN I JUN / 02
DextropropoxypheneN I JUN / 02
Dextrose sclerosing agents II SEP / 98
Dextrose injection concentrated solutions for parenteral injection I JAN / 03
DiampromideN I JUN / 02
Diazepam and its saltsTS I SEP / 98
Diazoxide or its saltsPDL I DEC / 13
Dibotermin alfaPDL

for veterinary use

I FEB / 14
Dichloroacetic acidPDL I DEC / 13
Diclofenac diethylamine when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days - in concentrations greater than 1.16% and less than or equal to 2.32% - in package sizes containing greater than 2.6g of diclofenac diethylamine II AUG / 14
Diclofenac diethylamine.

when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days - in concentrations greater than 1.16% and less than or equal to 2.32% - in package sizes containing no more than 2.6g of diclofenac diethylamine

III AUG / 14
Diclofenac diethylamine..

when sold as a single medicinal ingredient for topical use on the skin in concentrations of not more than 1.16% for not more than 7 days

U AUG / 14
Diclofenac or its saltsPDL

including (but not limited to): diclofenac diethylamine, diclofenac sodium, diclofenac potassium, except when sold as a single medicinal ingredient for topical use on the skin in a concentration equivalent to 2% or less of diclofenac for not more than 7 days

I AUG / 14
Dicyclomine and its salts except for topical use and lozenges II SEP / 98
Didanosine or its salts or derivativesPDL I DEC / 13
DiethylbromacetamidePDL I DEC / 13
Diethylcarbamazine or its saltsPDL I DEC / 13
Diethylpropion and any salt thereofC2 I JUN / 02
Diethylstilbestrol or its salts or derivativesPDL I DEC / 13
DiethylthiambuteneN I JUN / 02
DifenoxinN I JUN / 02
Difloxacin or its salts or derivativesPDL I DEC / 13
Diflunisal or its saltsPDL I DEC / 13
Digestive enzymes from plant sources U SEP / 99
Digoxin immune FabPDL

ovine

I DEC / 13
DihydrocodeineN I JUN / 02
DihydromorphineN I JUN / 02
Dihydroquinidine and its salts except phenylbarbiturate II SEP / 98
Dihydrostreptomycin or its salts or derivativesPDL

For human use

I DEC / 18
DihydrotachysterolPDL

for human use

I DEC / 13
DiiodohydroxyquinPDL

except in preparations for topical use on the skin

I DEC / 13
Diiodohydroxyquin

for topical use on the skin

II SEP / 98
Diltiazem or its saltsPDL I DEC / 13
Dimenhydrinate and its salts for parenteral use II SEP / 98
Dimenhydrinate and its salts. for oral or rectal use [Note: Pharmacists are advised that in areas where there is evidence of abuse or particular concern about abuse, dimenhydrinate products should not be located in a self-selection area of the pharmacy]. III APR / 99
DimenoxadolN I JUN / 02
DimepheptanolN I JUN / 02
DimercaprolPDL I DEC / 13
Dimethothiazine III SEP / 98
Dimethyl sulfoxidePDL

For human use, when sold for the treatment of interstitial cystitis or scleroderma

I DEC / 13
Dimethyl sulfoxidePDL

For veterinary use

I DEC / 13
DimethylaminodiphenylbutanonitrileN I JUN / 02
DimethylfumaratePDL I DEC / 13
DimethylthiambuteneN I JUN / 02
Dimeticone 100 cSt solution 50% w/w for topical use in the treatment of head lice III JAN / 13
Dinitrophenol or its salts or derivativesPDL I DEC / 13
DinutuximabPDL I DEC / 18
Dioxaphetyl butyrateN I JUN / 02
Diperodon and its salts except for topical use II SEP / 98
Diphenhydramine and its salts and preparations for parenteral use II SEP / 98
Diphenhydramine and its salts and preparations. except for parenteral or topical use III SEP / 98
Diphenhydramine and its salts and preparations.. for topical use in concentrations of greater than 2% II MAY / 06
Diphenhydramine and its salts and preparations... for topical use in concentrations of 2% or less when sold in containers of greater than 300 mg of diphenhydramine hydrochloride III MAY / 06
Diphenhydramine and its salts and preparations... for topical use in concentrations of 2% or less when sold in containers of 300 mg or less of diphenhydramine hydrochloride U OCT / 09
Diphenidol or its saltsPDL I DEC / 13
DiphenoxylateN I JUN / 02
Diphenylhydantoin (phenytoin) or its saltsPDL I SEP / 98
Diphenylmorpholinoisovaleric acidN I JUN / 02
Diphenylpyraline III SEP / 98
Diphtheria toxoid II DEC / 98
DipipanoneN I JUN / 02
Dipivefrin or its saltsPDL I DEC / 13
Diprophylline or its saltsPDL I DEC / 13
DipyridamolePDL I DEC / 13
DirithromycinPDL

For human use

I DEC / 13
DirlotapidePDL I DEC / 13
Disopyramide or its saltsPDL I DEC / 13
DisulfiramPDL I DEC / 13
Dithranol Anthralin II SEP / 98
Dobutamine or its saltsPDL I DEC / 13
Docetaxel or its derivativesPDL

including but not limited to cabazitaxel

I DEC / 13
Docosanol 10% for topical use U OCT / 02
Docusate and its salts U
Dolasetron or its saltsPDL I DEC / 13
Dolutegravir or its saltsPDL I DEC / 13
DomperidonePDL I DEC / 13
Donepezil or its saltsPDL I DEC / 13
Dopamine or its saltsPDL

when sold for administration by injection

I DEC / 13
DoravirinePDL I NOV / 18
Dornase alfaPDL I DEC / 13
Dorzolamide or its saltsPDL I DEC / 13
Doxacurium chloridePDL I DEC / 13
DoxapramPDL I DEC / 13
Doxazosin or its saltsPDL I DEC / 13
Doxepin or its saltsPDL I DEC / 13
Doxercalciferol or its derivativesPDL I DEC / 13
Doxorubicin or its saltsPDL I DEC / 13
Doxycycline or its salts or derivativesPDL

including but not limited to doxycycline hyclate, doxycycline monohydrate

I DEC / 13
Doxylamine or its salts

except those sold for nausea and vomiting of pregnancy

III SEP / 98
Doxylamine or its saltsPDL

when sold or recommended for use in the nausea or vomiting of pregnancy

I DEC / 13
Droperidol or its saltsPDL I DEC / 13
DrostanoloneC3 I JUN / 02
DrotebanolN I JUN / 02
DrotrecoginPDL I DEC / 13
DulaglutidePDL I JAN / 16
Duloxetine or its saltsPDL I DEC / 13
DupilumabPDL I MAR / 18
DurvalumabPDL I DEC / 17
DutasteridePDL I DEC / 13
Dyclonine except for topical use on mucous membranes II SEP / 98
Dyclonine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
EcgonineN I JUN / 02
Econazole or its saltsPDL I DEC / 13
Ecothiophate or its saltsPDL I DEC / 13
Ectylurea or its saltsPDL I DEC / 13
EculizumabPDL I DEC / 13
Edoxaban or its saltsPDL I FEB / 17
Edrophonium chloridePDL I DEC / 13
EfalizumabPDL I DEC / 13
EfavirenzPDL I DEC / 13
EfinaconazolePDL I DEC / 13
Eflornithine or its salts or derivativesPDL I DEC / 13
Elagolix or its salts PDL I DEC / 18
Elbasvir or its saltsPDL I AUG / 16
Electrolyte solutions for oral rehydration III SEP / 98
Eletriptan or its saltsPDL I DEC / 13
Eliglustat or its saltsPDL I MAY / 17
Elosulfase alfaPDL I AUG / 14
ElotuzumabPDL I AUG / 16
Eltrombopag or its saltsPDL

including but not limited to eltrombopag olamine

I DEC / 13
Eluxadoline or its saltsPDL I APR / 17
Elvitegravir or its salts or derivativesPDL I DEC / 18
Emamectin or its saltsPDL

including but not limited to emamectin benzoate

I DEC / 13
EmbutramidePDL I DEC / 13
Emedastine or its saltsPDL I DEC / 13
EmicizumabPDL I OCT / 18
EmpagliflozinPDL I OCT / 15
EmtricitabinePDL I DEC / 13
EmylcamatePDL I DEC / 13
Enalapril or its salts or derivativesPDL

including but not limited to enalapril maleate

I DEC / 13
Enasidenib or its saltsPDL I MAR / 19
Encephalitis vaccine (Japanese) I FEB / 02
EnestebolC3 I JUN / 02
EnfluranePDL I DEC / 13
EnfuvirtidePDL I DEC / 13
Enoxaparin or its saltsPDL I DEC / 13
EnrofloxacinPDL I DEC / 13
EntacaponePDL I DEC / 13
EntecavirPDL I DEC / 13
EnzalutamidePDL I DEC / 13
Ephedrine and its salts

in preparations containing more than 8 mg per unit dose, or with a label recommending more than 8 mg/dose or 32 mg/day, or labelled or implied for use exceeding 7 days, or if indicated for other than nasal congestion.

I FEB / 02
Ephedrine and its salts in combination products in preparations containing no more than 8 mg per unit dose, with a label recommending no more than 8 mg/dose or 32 mg/day and for use not more than 7 days, and indicated for nasal congestion. III APR / 06
Ephedrine and its salts in single entity products. in preparations containing no more than 8 mg per unit dose, with a label recommending no more than 8 mg/dose or 32 mg/day and for use not more than 7 days, and indicated for nasal congestion. II APR / 06
Epinephrine and its salts in pre-filled syringes intended for emergency administration by injection in the event of anaphylactic reactions to allergens II SEP / 99
Epinephrine and its salts. other than in pre-filled syringes intended for emergency administration by injection in the event of anaphylactic reactions to allergens I SEP / 99
Epirubicine or its saltsPDL I DEC / 13
EpitiostanolC3 I JUN / 02
EplerenonePDL I DEC / 13
Eprosartan or its salts or derivativesPDL I DEC / 13
EpsiprantelPDL I DEC / 13
Eptifibatide or its saltsPDL I DEC / 13
ErenumabPDL I OCT / 18
Ergot alkaloids or their saltsPDL

for human use

I DEC / 13
Eribulin or its salts or derivativesPDL

including but not limited to eribulin mesylate

I DEC / 13
Erlotinib or its saltsPDL I DEC / 13
Ertugliflozin or its derivativesPDL I JUL / 18
Erythrityl tetranitrate I SEP / 98
Erythromycin or its salts or derivativesPDL

Including but not limited to: azithromycin, clarithromycin, gamithromycin, telithromycin, tulathromycin

I DEC / 18
Erythropoiesis stimulating hormonePDL

including but not limited to erythropoietin, darbepoetin alpha, epoetin alfa

I DEC / 13
Escitalopram or its saltsPDL I DEC / 13
Esdepallethrin/piperonyl butoxide II SEP / 98
Eslicarbazepine acetatePDL I AUG / 14
Esmolol or its saltsPDL I DEC / 13
Esomeprazole or its saltsPDL

for veterinary use

I DEC / 13
Esomeprazole or its salts

For human use, including but not limited to esomeprazole magnesium, EXCEPT when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of esomeprazole

I NOV / 18
Esomeprazole or its salts

For human use, when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of esomeprazole

III NOV / 18
Estazolam and its saltsTS I SEP / 98
Estramustine or its saltsPDL I DEC / 13
EtanerceptPDL I DEC / 13
Ethacrynic acidPDL I DEC / 13
Ethambutol or its saltsPDL I DEC / 13
Ethanolamine oleate II SEP / 98
EthchlorvynolTS I SEP / 98
EthinamateTS I SEP / 98
Ethionamide or its saltsPDL I DEC / 13
Ethoheptazine and its salts II SEP / 98
Ethomoxane or its saltsPDL I DEC / 13
Ethotoin or its saltsPDL I DEC / 13
Ethyl Chloride except in trace amounts II SEP / 98
Ethyl LoflazepateTS I JUN / 02
Ethyl trichloramatePDL I DEC / 13
EthylestrenolC3 I JUN / 02
EthylmethylthiambuteneN I JUN / 02
EthylmorphineN I JUN / 02
Ethylpapaverine and its salts I SEP / 98
Etidronic acid or its saltsPDL I DEC / 13
Etodolac or its salts or derivativesPDL I DEC / 13
EtonitazeneN I JUN / 02
Etoposide or its derivativesPDL I DEC / 13
EtorphineN I JUN / 02
EtoxeridineN I JUN / 02
Etravirine or its saltsPDL I DEC / 13
EtretinatePDL I DEC / 13
Etryptamine and its salts I SEP / 98
Etymemazine or its saltsPDL I DEC / 13
EvolocumabPDL I JAN / 16
ExemestanePDL I DEC / 13
Exenatide or its saltsPDL I DEC / 13
EzetimibePDL I DEC / 13
Ezogabine or its salts or derivativesPDL I DEC / 13
Famciclovir or its saltsPDL I DEC / 13
Famotidine and its salts. when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 600 mg of famotidine III MAY / 08
Famotidine and its salts.. when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing no more than 600 mg of famotidine U FEB / 07
Famotidine or its saltsPDL

except when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn for human use

I DEC / 13
Famotidine or its saltsPDL

For veterinary use

I DEC / 13
Fampridine or its salts or derivativesPDL I DEC / 13
Febuxostat or its salts or derivativesPDL I DEC / 13
Felodipine or its saltsPDL I DEC / 13
Fenetylline and any salt thereofC5 I JAN / 03
Fenfluramine or its saltsPDL

including but not limited to dexfenfluramine

I DEC / 13
FenofibratePDL I DEC / 13
Fenoprofen or its saltsPDL I DEC / 13
Fenoterol or its saltsPDL I DEC / 13
FenproporexTS I JUN / 02
FentanylN I JUN / 02
Fesoterodine or its saltsPDL I DEC / 13
Fexofenadine hydrochloride in products marketed for adult use (12 years and older) U APR / 07
Fexofenadine hydrochloride. in products marketed for paediatric use (under 12 years of age) III APR / 07
Fibrin II SEP / 98
Fibrinolysin II SEP / 98
Fidaxomicin or its derivativesPDL I DEC / 13
FilgrastimPDL I DEC / 13
Finafloxacin or its salts or its derivativesPDL I AUG / 16
FinasteridePDL I DEC / 13
Fingolimod or its salts or derivativesPDL

including but not limited to fingolimod hydrochloride

I DEC / 13
FirocoxibPDL I DEC / 13
Flavoxate or its saltsF1 I DEC / 13
Flecainide or its saltsPDL I DEC / 13
Fleroxacin and its salts and derivativesPDL I DEC / 13
Flibanserin or its saltsPDL I MAY / 18
FloctafeninePDL I DEC / 13
Florfenicol or its derivativesPDL I DEC / 13
FluconazolePDL

For veterinary use

I DEC / 13
FluconazolePDL

 except when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis for human use

I DEC / 13
Fluconazole

when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis, in package sizes containing no more than 150 mg of fluconazole for human use

III MAR / 10
FlucytosinePDL I DEC / 13
Fludarabine or its salts and derivativesPDL I DEC / 13
FludiazepamTS I JUN / 02
Flumazenil I SEP / 98
Flunarizine or its saltsPDL I DEC / 13
FlunitrazepamTS I JUN / 02
Flunixin or its salts and derivativesPDL

including but not limited to flunixin meglumine

I DEC / 13
Fluoride or its salts (see sodium fluoride)PDL

in solid oral dosage forms containing more than 1 mg of fluoride ion for human use

I DEC / 13
Fluoride or its salts (see sodium fluoride).

in oral preparations containing 1 mg or less of fluoride ion per dosage unit

III SEP / 98
Fluorouracil or its derivativesPDL

including but not limited to capecitabine, tegafur

I DEC / 13
Fluoxetine or its saltsPDL I DEC / 13
FluoxymesteroneC3 I JUN / 02
Flupentixol or its salts and derivativesPDL

including but not limited to flupentixol decanoate

I DEC / 13
Fluphenazine or its saltsPDL I DEC / 13
FluralanerPDL I JUN / 14
Flurazepam and its saltsTS I SEP / 98
Flurbiprofen or its saltsPDL I JAN / 13
FluspirilenePDL I DEC / 13
FlutamidePDL I DEC / 13
Fluticasone propionate when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing no more than 120 metered sprays III AUG / 16
Fluticasone propionate when sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing more than 120 metered sprays II AUG / 16
Fluvastatin or its salts and derivativesPDL I DEC / 13
Fluvoxamine or its saltsPDL I DEC / 13
Folic acidPDL

in oral dosage form containing more than 1.0 milligram of folic acid per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1.0 milligram of folic acid for human use

I DEC / 13
Follicle stimulating hormonePDL

including but not limited to: follitropin alpha, follitropin beta, follitropin delta

I DEC / 13
Fomepizole or its saltsPDL I DEC / 13
Fondaparinux sodiumPDL I DEC / 13
FormeboloneC3 I SEP / 98
Formestane or its derivativesPDL I DEC / 13
Formoterol or its saltsPDL I DEC / 13
Foscarnet sodiumPDL I DEC / 13
Fosfomycin or its saltsPDL I DEC / 13
Fosinopril and its saltsPDL I DEC / 13
Fosphenytoin or its saltsPDL I DEC / 13
Fractar III SEP / 98
Framycetin or its salts and derivativesPDL

for human use 

I DEC / 13
Frovatriptan or its saltsPDL I DEC / 13
FulvestrantPDL I DEC / 13
Furaltadone or its saltsPDL

for human use

I DEC / 13
FurazabolC3 I SEP / 98
Furazolidone or its saltsPDL I DEC / 13
FurethidineN I JUN / 02
FurosemidePDL

for human use

I DEC / 13
Fusidic acid or its saltsPDL I DEC / 13
Gabapentin or its salts and derivativesPDL I DEC / 13
Galantamine or its salts and derivativesPDL I DEC / 13
Gallamine triethiodidePDL I DEC / 13
Gallium or its saltsPDL I DEC / 13
GalsufasePDL I DEC / 13
Gamithromuycin PDL I DEC / 13
Ganciclovir or its saltsPDL I DEC / 13
Ganirelix or its salts and derivativesF1

including but not limited to ganirelix acetate 

I DEC / 13
Gatifloxacin and its salts and derivativesPDL I DEC / 13
GefitinibPDL I DEC / 13
Gemcitabine or its saltsPDL I DEC / 13
Gemfibrozil or its saltsPDL I DEC / 13
Gemifloxacin or its saltsPDL I DEC / 13
Gentamicin or its salts and derivativesPDL

including but not limited to netilmicin

I DEC / 13
Gentian Violet II DEC / 01
Glatiramer or its saltsPDL I DEC / 13
GlecaprevirPDL I SEP / 17
GliclazidePDL I DEC / 13
GlimepiridePDL I DEC / 13
GlipizidePDL I DEC / 13
Glucagon II SEP / 98
Glutamic acid and its salts gastric acidifiers U FEB / 99
GlutethimideC1 U SEP / 98
Glyburide or its salts and derivativesPDL I DEC / 13
Glyceroargentinate III SEP / 98
Glycopyrrolate or its salts

except glycopyrronium bromide, including but not limited to glycopyrrolate, when used orally or for inhalation

II DEC / 17
Glycopyrronium bromidePDL

including but not limited to glycopyrrolate, when used orally or for inhalation

I DEC / 17
Gold or its salts or derivativesPDL

including but not limited to aurothioglucose, auranofin and sodium aurothiomalate, when sold for administration by injection

I DEC / 13
GolimumabPDL I DEC / 13
Gonadorelin or its saltsPDL I DEC / 13
Gonadotropin releasing factor or its analoguesPDL I DEC / 13
Gonadotropin, chorionic (human)PDL I DEC / 13
Gonadotropins, serum (human)PDL I DEC / 13
Goserelin or its saltsPDL I DEC / 13
Gramicidin and its salts for topical use U
Gramicidin and its salts and derivatives for ophthalmic use III JUN / 06
Granisetron or its saltsPDL I DEC / 13
Grapiprant or its saltsPDL

For veterinary use

I FEB / 19
GrazoprevirPDL I AUG / 16
Grepafloxacin or its salts and derivativesPDL I DEC / 13
Griseofulvin and its salts and derivativesPDL I DEC / 13
Guaifenesin U
Guanethidine and its saltsPDL I DEC / 13
Guanfacine or its salts or derivativesPDL I DEC / 13
GuselkumabPDL I MAR / 18
Haemophilus influenzae type B vaccine II DEC / 98
Halazepam and its saltsTS I SEP / 98
Halofantrine or its saltsPDL I DEC / 13
Halofuginone or its saltsPDL

for veterinary use

I MAY / 18
HaloperidolPDL I DEC / 13
Haloprogin III SEP / 98
HalothanePDL I DEC / 13
HaloxazolamTS I JUN / 02
HeminPDL I AUG / 18
Heparin and its salts for topical use III SEP / 98
Heparin and its salts. except for topical use II SEP / 99
Hepatitis A vaccine I FEB / 02
Hepatitis B Adult vaccine I FEB / 02
Hepatitis B Pediatric vaccine II DEC / 98
Hepatitis B immune globulin I FEB / 02
HeptabarbitalC2 I JUN / 02
Hetacillin or its salts or derivativesPDL I DEC / 13
Hetastarch and its derivativesPDL I DEC / 13
Hexachlorophene or its saltsPDL I DEC / 13
Hexacyclonate sodiumPDL I DEC / 13
Hexamethonium or its saltsPDL I DEC / 13
HexethalC2 I JUN / 02
HexobarbitalC2 I JUN / 02
Histamine and its salts except for topical use II SEP / 98
Histrelin and its saltsPDL I DEC / 13
Homatropine and its salts for oral use in concentrations of 2 mg or less per dosage unit II SEP / 98
Homatropine and its salts for ophthalmic or parenteral use or in preparations for oral use containing more than 2 mg per dosage unit I SEP / 98
Human insulinD II SEP / 98
Hyaluronic acid and its salts preparations in concentrations of 5% or more II SEP / 98
Hyaluronic acid or its saltsPDL

when sold or recommended for administration by intra-articular injection to horses for veterinary use

I DEC / 13
Hyaluronidase II SEP / 98
Hydralazine or its saltsPDL I DEC / 13
HydrocodoneN I JUN / 02
Hydrocortisone aceponatePDL I DEC / 13
Hydrocortisone or hydrocortisone acetate

when sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in children under 2 years of age

I DEC / 14
Hydrocortisone or hydrocortisone acetate.

when sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in adults and children 2 years of age and over in package sizes containing more than 30 g

I DEC / 14
Hydrocortisone or hydrocortisone acetate..

when sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in adults and children 2 years of age and over in package sizes containing no more than 30 g

III DEC / 14
HydromorphinolN I JUN / 02
HydromorphoneN I JUN / 02
Hydroquinone or its derivativesPDL

When sold in a concentration greater than 2% in preparations for topical use on the skin.

I JUN / 19
Hydroquinone or its derivatives

When sold in a concentration less than or equal to 2% in preparations for topical use on the skin

II JUN / 19
Hydroxocobalamin or its saltsPDL

when recommended as an antidote for cyanide poisoning

I DEC / 13
Hydroxychloroquine or its saltsPDL I DEC / 13
Hydroxycoumarin or its derivativesPDL

including but not limited to acenocoumarol when sold or recommended as anticoagulants

I DEC / 13
Hydroxyephedrine and its salts II SEP / 98
HydroxypethidineN I JUN / 02
HydroxyureaPDL I DEC / 13
Hydroxyzine or its salts or derivativesPDL

including but not limited to cetirizine and hydroxyzine hydrochloride. cetirizine or its salts when sold in concentration greater than 8.5 milligrams cetirizine per unit dose.

I DEC / 13
Hyoscine and its salts and derivatives [scopolamine] except Hyoscine butylbromide, when recommended for parenteral use II AUG / 16
Hyoscine butylbromidePDL

when recommended for parenteral use

I AUG / 16
Hyoscyamine and its salts and derivatives except for topical use II SEP / 98
IbafloxacinPDL I DEC / 13
Ibandronic acid or its saltsPDL I DEC / 13
Ibogaine or its salts or derivatives or analoguesPDL I MAY / 17
Ibrutinib or its saltsPDL I DEC / 14
Ibuprofen or its saltsPDL I DEC / 13
Ibuprofen or its saltsPDL

except when sold in an oral dosage form that provides 400 mg or less per dosage unit or in a modified-release oral dosage form that provides 600 mg or less per dosage unit for human use

I AUG / 16
Ibuprofen or its salts. when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes exceeding 18,000 mg) III FEB / 12
Ibuprofen or its salts..

when sold in a modified-release oral dosage form that provides 600 mg or less per dosage unit

III AUG / 16
Ibuprofen or its salts... when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes of up to 18,000 mg) U FEB / 12
Ibutilide or its salts and derivativesPDL I DEC / 13
Icatibant or its saltsPDL

including but not limited to Icatibant acetate

I AUG / 14
Idarubicin or its saltsPDL I DEC / 13
IdarucizumabPDL I AUG / 16
IdebenonePDL I DEC / 13
IdelalisibPDL I MAY / 15
IdoxuridinePDL I DEC / 13
IdursulfasePDL I DEC / 13
IfosfamidePDL I DEC / 13
Imatinib and its saltsPDL I DEC / 13
Imidapril or its saltsPDL I DEC / 13
ImiglucerasePDL I DEC / 13
Imipramine or its saltsPDL I DEC / 13
Imiquimod or its saltsPDL I DEC / 13
Immune globulin products I FEB / 02
Immunogenic substancesPDL I DEC / 13
Indacaterol or its salts or derivativesPDL I DEC / 13
Indapamide or its saltsPDL I DEC / 13
Indinavir or its saltsPDL I DEC / 13
IndomethacinPDL I DEC / 13
InfliximabPDL I DEC / 13
Influenza vaccine II DEC / 98
Ingenol mebutate or its derivativesPDL I DEC / 13
Inhaled human insulinPDL I DEC / 13
InosiplexPDL I DEC / 13
Inositol niacinate U DEC / 98
Inotersen or its saltsPDL I NOV / 18
Inotuzumab ozogamicinPDL I MAY / 18
InsulinD II SEP / 98
InterferonPDL I DEC / 13
Iodinated glycerol II SEP / 98
Iodine and its salts and derivatives except topical preparations or in oral doses of 1 mg or less per day II DEC / 98
Iodine and its salts and derivatives for topical use III SEP / 98
Iodochlorhydroxyquin for topical use II SEP / 98
IodochlorohydroxyquinPDL

For veterinary use

I DEC / 13
IodochlorohydroxyquinPDL

except in preparations for topical use on the skin for human use

I DEC / 13
Ipecac and its extracts and derivatives when used as an emetic II OCT / 98
Ipecac and its extracts and derivatives. for use other than as an emetic U OCT / 98
IpilimumabPDL I DEC / 13
Ipratropium or its saltsPDL I DEC / 13
Iproniazid or its saltsPDL I DEC / 13
Irbesartan or its saltsPDL I DEC / 13
Irinotecan or its saltsPDL I DEC / 13
Iron and its salts and derivatives in preparations with more than 30 mg elemental iron per solid dosage unit or 5 mL oral liquid II SEP / 98
Iron and its salts and derivatives. in preparations containing 30 mg or less elemental iron per solid dosage unit or 5 ml oral liquid U
Iron derivativesPDL

for human use, including but not limited to ferumoxytol, iron isomaltoside 1000, for parenteral use only

I DEC / 13
Iron derivativesPDL

for veterinary use, including but not limited to ferumoxytol, for all routes of administration but parenteral

I DEC / 13
Isavuconazole or its saltsPDL I FEB / 19
Isocarboxazid or its saltsPDL I DEC / 13
IsofluranePDL I DEC / 13
IsomethadoneN I JUN / 02
IsoniazidPDL I DEC / 13
Isopropamide and its salts I SEP / 98
Isopropyl myristate in concentration of 50%

for use in the treatment of head lice

III JUL / 07
Isoproterenol (Isoprenaline) or its saltsF1 I DEC / 13
Isosorbide and its salts I SEP / 98
Isotretinoin or its saltsPDL I DEC / 13
Isoxsuprine or its saltsPDL I DEC / 13
Isradipine or its saltsPDL I DEC / 13
Itraconazole or its saltsPDL I DEC / 13
Ivabradine or its salts or derivativesPDL I FEB / 17
Ivacaftor or its derivativesPDL I DEC / 13
Ivermectin and its derivativesF1 for human use or for veterinary use when sold for intramuscular injection into horses or for administration to dogs and cats I MAY / 04
Ixazomib or its derivativesPDL I NOV / 16
IxekizumabPDL I AUG / 16
Kanamycin or its salts and derivativesPDL

for human use

I DEC / 13
Ketamine and its saltsN I AUG / 05
Ketanserin or its saltsPDL I DEC / 13
Ketazolam and its saltsTS I SEP / 98
KetobemidoneN I JUN / 02
Ketoconazole and its salts. as a shampoo U
Ketoconazole or its saltsPDL

except in preparations for topical use as a shampoo for human use

I DEC / 13
Ketoconazole or its saltsPDL

For veterinary use

I DEC / 13
Ketoprofene or its saltsPDL I DEC / 13
Ketorolac or its saltsPDL I DEC / 13
Ketotifen or its saltsPDL I DEC / 13
L-TryptophanPDL

when sold, a) for human use in oral dosage form at a concentration of more than 220 mg per dosage unit or per daily dose, as a single ingredient or in combination with other indredients; or b) for human or veterinary use as a single ingredient inteded for any route of administration other than oral

I DEC / 13
Labetalol or its saltsPDL I DEC / 13
Lacosamide or its derivativesPDL I DEC / 13
Lactic acidPDL

when recommended for parenteral use as a tissue sclerosing agent

I DEC / 13
Lactic acid.

in preparations in concentrations of more than 10% except when sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.0 for a use other than to be applied to warts, corns or calluses

III DEC / 14
Lactulose III SEP / 98
Lamivudine or its saltsPDL I DEC / 13
Lamotrigine or its saltsPDL I DEC / 13
LanadelumabPDL I NOV / 18
Lanreotide or its saltsPDL I DEC / 13
Lansoprazole and its saltsPDL I DEC / 13
Lanthanum saltsPDL

when sold for the treatment of hyperphosphatemia for human use

I DEC / 13
Lapatinib or its saltsPDL I DEC / 13
LaronidasePDL I DEC / 13
Ledipasvir or its saltsPDL I DEC / 14
Lefetamine and any Salt thereofC4 I JAN / 03
Leflunomide or its salts or derivativesPDL

including but not limited to teriflunomide 

I DEC / 13
LenalidomidePDL I DEC / 13
Lenvatinib or its saltsPDL I AUG / 16
Letermovir or its saltsPDL I DEC / 17
LetrozolePDL I DEC / 13
Leucovorin or its saltsPDL I DEC / 13
Leuprolide or its saltsPDL I DEC / 13
Levallorphane and its salts I SEP / 98
Levamisole or its saltsPDL

for human use 

I DEC / 13
Levargorphane and its salts II SEP / 98
LevetiracetamPDL I DEC / 13
Levobunolol or its saltsPDL I DEC / 13
Levocabastine or its salts or derivativesPDL I DEC / 13
Levocarnitine or its salts or derivativesPDL

when sold for the treatment of primary or secondary levocarnitine deficiency

I DEC / 13
Levodopa or its saltsPDL I DEC / 13
LevomethorphanN I JUN / 02
Levomilnacipran or its saltsPDL I JUN / 15
LevomoramideN I JUN / 02
Levonordefrine II SEP / 98
Levonorgestrel when sold in concentrations of 1.5 mg or less per oral dosage unit (except when labelled to be taken as a single dose of 1.5 mg and in package sizes containing no more than 1.5 mg levonorgestrel, packaged and labelled for emergency contraception.) II MAY / 15
Levonorgestrel. when sold in concentrations of 1.5 mg or less per oral dosage unit to be taken as a single dose of 1.5 mg, packaged and labelled for emergency contraception, in package sizes containing no more than 1.5 mg of levonorgestrel III MAY / 15
LevophenacylmorphanN I JUN / 02
LevorphanolN I JUN / 02
LidocainePDL

when in a preparation containing an equal amount of tetracaine and recommended for topical use on the skin, in concentrations of 7% or higher for human use

I FEB / 14
Lidocaine and its salts for ophthalmic or parenteral use, or topical use on mucous membranes, except lozenges II SEP / 98
Lidocaine and its salts.

for otic use

III JUN / 06
Lidocaine and its salts..

for topical use on the skin, including lozenges [except when in a preparation containing an equal amount of tetracaine and recommended for topical use on the skin, in concentrations of 7% or higher]

U FEB / 14
Lidocaine and prilocaine eutectic mixture III FEB / 99
Lifitegrast or its saltsPDL I MAR / 18
Linaclotide or its salts or derivativesPDL I DEC / 13
Linagliptin or its salts or derivativesPDL I DEC / 13
Lincomycin or its salts or derivativesPDL

Including but not limited to: Clindamycin 

I DEC / 18
Lindane II SEP / 98
Linezolid or its saltsPDL I DEC / 13
Liothyronine or its saltsPDL

for human use 

I DEC / 13
Lipid solutions in injectable form for parenteral nutrition I JAN / 03
Liraglutide or its saltsPDL I DEC / 13
Lisinopril or its salts or derivativesPDL I DEC / 13
Lithium or its saltsPDL I DEC / 13
Lixisenatide or its saltsPDL I JUN / 17
Lodoxamide or its salts or derivativesPDL

including but not limited to Lodoxamide tromethamine

I DEC / 13
Lomefloxacin or its saltsPDL I DEC / 13
Lomitapide or its saltsPDL I FEB / 14
LomustinePDL I DEC / 13
Loperamide and its salts in products marketed for adult use (12 years and older) U APR / 07
Loperamide and its salts. in products marketed for paediatric use (under 12 years of age) II APR / 07
LopinavirPDL I DEC / 13
LoprazolamTS I JUN / 02
Loratadine and its salts and preparations in products marketed for paediatric use - under 12 years of age III OCT / 02
Loratadine and its salts and preparations. in products marketed for adult use - 12 years and older U OCT / 02
Lorazepam and its saltsTS I SEP / 98
Lorlatinib or its salts PDL I MAR / 19
LormetazepamTS I JUN / 02
Losartan or its saltsPDL I DEC / 13
Losoxantrone or its saltsPDL I DEC / 13
LotilanerPDL

For veterinary use

I MAR / 18
LovastatinPDL

except in oral dosage form that provides 1 milligram (mg) or less per daily dose

I DEC / 14
Loxapine or its saltsPDL I DEC / 13
Lumacaftor or its salts or derivativesPDL I AUG / 16
LumiracoxibPDL I DEC / 13
Lurasidone or its saltsPDL I DEC / 13
Lutropin alfaPDL I DEC / 13
Lyme Disease vaccine I FEB / 02
Macitentan or its derivativesPDL I DEC / 13
Magnesium citrate cathartics III SEP / 98
Magnesium glutamate hydrobromidePDL I DEC / 13
Magnesium salicylate except oral dosage forms which also contain choline salicylate III SEP / 98
Magnesium sulfate for parenteral use II SEP / 98
Magnesium sulfate in injectable form for parenteral nutrition I JAN / 03
Manganese and its salts in injectable form for parenteral nutrition I JAN / 03
Mannitol and its salts II SEP / 98
Maprotiline and its saltsPDL I DEC / 13
MaravirocPDL I DEC / 13
Marbofloxacin and its salts and derivativesPDL I DEC / 13
Maropitant or its saltsPDL I DEC / 13
Mazindol and its saltsTS I SEP / 98
Measles vaccine II DEC / 98
MebendazolePDL

for human use

I DEC / 13
MebendazolePDL

For veterinary use when sold to treat dogs only

I DEC / 13
MebolazineC3 I JUN / 02
Mecamylamine or its saltsPDL I DEC / 13
Mechlorethamine or its saltsPDL I DEC / 13
Mecillinam or its salts or derivativesPDL I DEC / 13
Meclizine and its salts.

when sold in concentrations of 25 mg or less per dosage unit

III MAY / 00
Meclizine or its saltsPDL

when sold in concentrations greater than 25 mg per dosage unit for human use

I DEC / 13
Meclofenamic acid or its saltsPDL I DEC / 13
Mecloqualone and any salt thereofC5 I JAN / 03
MedazepamTS I JUN / 02
Medetomidine or its saltsPDL I DEC / 13
Mefenamic acid or its saltsPDL I DEC / 13
MefenorexTS I JUN / 02
Mefloquine or its salts and derivativesPDL I DEC / 13
Megestrol or its saltsPDL I DEC / 13
Melanoma therapeutic vaccinePDL I DEC / 13
Melarsomine or its saltsPDL

For human use

I DEC / 13
Melarsomine or its saltsPDL

when sold for the treatment of heartworm in dogs for veterinary use

I DEC / 13
Meloxicam or its salts or derivativesPDL I DEC / 13
MelphalanPDL I DEC / 13
Memantine or its saltsPDL I DEC / 13
Meningococcus vaccine II MAR / 01
Menotropins (human)PDL I DEC / 13
Mepacrine or its saltsPDL I DEC / 13
Mepazine or its saltsPDL I DEC / 13
MephenoxalonePDL I DEC / 13
Mephentermine or its saltsPDL I DEC / 13
MephobarbitalC2 I JUN / 02
Mepivacaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Mepivacaine and its salts for ophthalmic or parenteral use II SEP / 98
MepolizumabPDL I AUG / 16
MeprobamateTS I SEP / 98
Mepyramine see pyrilamine U
MercaptopurinePDL I DEC / 13
MesaboloneC3 I JUN / 02
MesnaPDL I DEC / 13
Mesocarb and any salt thereofC4 I JAN / 03
Mesoridazine or its saltsPDL I DEC / 13
MesteroloneC3 I JUN / 02
MetaldehydePDL I DEC / 13
MetandienoneC3 I JUN / 02
Metaraminol bitartrate I SEP / 98
Metathoheptazine and its salts II SEP / 98
MetazocineN I JUN / 02
MetenoloneC3 I JUN / 02
Metformin or its salts or derivativesPDL I DEC / 13
MethabarbitalC2 I JUN / 02
Methacholine chloridePDL I DEC / 13
MethadoneN I JUN / 02
MethamphetamineC1 I JUN / 02
MethandriolC3 I JUN / 02
Methantheline and its salts II SEP / 98
MethaqualoneC1 I JUN / 02
Methazolamide and its saltsPDL I DEC / 13
Methdilazine and its salts II SEP / 98
Methenamine and its salts except for topical use II SEP / 98
Metheptazine and its salts II SEP / 98
Methicillin or its salts or derivativesPDL I DEC / 13
MethimazolePDL I DEC / 13
MethisazonePDL I DEC / 13
Methocarbamol for parenteral use II SEP / 98
Methocarbamol. except for parenteral use III SEP / 98
Methoin (Mephenytoin) or its saltsPDL I DEC / 13
Methotrexate or its saltsPDL I DEC / 13
Methotrimeprazine or its saltsF1 I DEC / 13
Methoxamine or its saltsPDL I DEC / 13
MethoxsalenPDL I DEC / 13
Methoxy polyethylene glycol-epoetin betaPDL I DEC / 13
MethoxyfluranePDL I MAY / 18
Methyl salicylate in liquid dosage forms in concentrations greater than 30% II SEP / 98
Methyl salicylate. in liquid dosage forms in concentrations up to and including 30% U
MethyldesorphineN I JUN / 02
MethyldihydromorphineN I JUN / 02
Methyldopa or its saltsPDL I DEC / 13
Methylene Blue for parenteral use II SEP / 98
Methylnaltrexone or its saltsPDL

including but not limited to methylnaltrexone bromide

I JUN / 15
MethylparafynolPDL I DEC / 13
MethylphenidateC1 I JUN / 02
MethylphenobarbitalC2 I JUN / 02
MethylphenylisonipecotonitrileN I JUN / 02
MethyltestosteroneC3 I JUN / 02
MethyprylonTS I SEP / 98
Methysergide or its salts or derivativesPDL I DEC / 13
MetoclopramidePDL I DEC / 13
Metolazone or its saltsPDL I DEC / 13
Metomidate or its saltsPDL I DEC / 13
Metopimazine or its saltsPDL I DEC / 13
MetoponN I JUN / 02
Metoprolol or its saltsPDL I SEP / 98
MetriboloneC3 I JUN / 02
MetronidazolePDL I DEC / 13
Metyrapone or its saltsPDL I DEC / 13
Mexiletine or its saltsPDL I DEC / 13
Mezlocillin or its salts or derivativesPDL

For veterinary use

I DEC / 13
MiboleroneC3 I JUN / 02
Micafungin or its saltsPDL I DEC / 13
Miconazole and its salts. for vaginal use III SEP / 98
Miconazole and its salts.. for topical use U
Miconazole or its saltsPDL

except in preparations for topical or vaginal use for human use

I DEC / 13
Miconazole or its saltsPDL

For veterinary use

I DEC / 13
Midazolam and its saltsTS I SEP / 98
Midodrine or its saltsPDL I DEC / 13
Midostaurin or its saltsPDL I SEP / 17
Mifepristone or its derivativesPDL I AUG / 15
Migalastat or its saltsPDL I DEC / 17
MiglustatPDL I DEC / 13
Milbemycin or its derivativesPDL

For veterinary use.  Including but not limited to Moxidectin. Moxidectin when sold for the prevention of heartworm in dogs.

I DEC / 13
Milbemycin or its derivativesPDL

For human use.  Including but not limited to moxidectin 

I DEC / 13
Milrinone or its saltsPDL I DEC / 13
Mineral tar except shampoos with concentrations less than 5% III SEP / 98
MinoxidilPDL

For veterinary use

I DEC / 13
MinoxidilPDL

except when sold in preparations for topical use in concentrations of 5% or less, for human use only

I AUG / 14
Minoxidil.

when sold in preparations for topical use in adults in concentrations of 5% or less, for human use only

U JUL / 17
Mirabegron or its saltsPDL I DEC / 13
Mirtazapine or its saltsPDL I DEC / 13
Mitomycin and its saltsPDL I DEC / 13
MitotanePDL I DEC / 13
Mitoxantrone or its saltsPDL I DEC / 13
MitratapidePDL I FEB / 14
Mivacurium chloridePDL I DEC / 13
Moclobemide or its salts or derivativesPDL I DEC / 13
Modafinil or its saltsPDL I DEC / 13
MolgramostimPDL I DEC / 13
Mometasone furoateNR for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 12 years of age and older I AUG / 15
Monobenzone II SEP / 98
Monoethanolamine oleate II SEP / 98
Montelukast or its saltsPDL I DEC / 13
MorpheridineN I JUN / 02
MorphineN I JUN / 02
Morphine-N-oxideN I JUN / 02
Moxifloxacin or its salts or derivativesPDL I DEC / 13
Mumps vaccine II DEC / 98
Mupirocin I SEP / 99
Muromonab-CD3PDL I DEC / 13
Mycophenolic acid or its salts or derivativesPDL

including but not limited to Mycophenolate mofetil

I DEC / 13
MyrophineN I JUN / 02
NabumetonePDL I DEC / 13
Nadolol or its saltsPDL I DEC / 13
Nadroparin or its saltsPDL I DEC / 13
Nafarelin and its salts and derivativesPDL

Including but not limited to Nafarelin acetate

I DEC / 13
Nafcillin or its salts or derivativesPDL

For veterinary use

I DEC / 13
Nalbuphine and any salt thereofC2 I JUN / 02
Nalidixic acidPDL I DEC / 13
Nalmefene and its saltsPDL I DEC / 13
NalorphineN I JUN / 02
Naloxegol or its saltsPDL

including but not limited to naloxegol oxalate

I JUN / 15
Naloxone hydrochloride injection,

when indicated for emergency use for opioid overdose

Note: Pharmacists should verify whether there is any additional guidance in their jurisdiction regarding the provision of this drug.

II FEB / 17
Naloxone hydrochloride nasal spray,

when indicated for emergency use for opioid overdose

Note: Pharmacists should verify whether there is any additional guidance in their jurisdiction regarding the provision of this drug.

II FEB / 17
Naloxone or its saltsPDL

including, but not limited to naloxone hydrochloride, except when indicated for emergency use for opioid overdose

I FEB / 17
Naltrexone or its salts PDL I DEC / 13
NandroloneC3 I JUN / 02
Naphazoline and its salts in nasal preparations for pediatric use II SEP / 98
Naphazoline and its salts. in nasal preparations for adult use and in ophthalmic products U
Naproxen or its salts

except in preparations containing the equivalent of 200 mg of naproxen base* per oral dosage unit when sold in products labelled with a recommended maximum daily dose equivalent to 400 mg of naproxen base)

[*220 mg naproxen sodium approximately equivalent to 200 mg naproxen base]

I MAR / 15
Naproxen or its salts..

in preparations containing the equivalent of 200 mg of naproxen base* per oral dosage unit, when sold in products labelled with a recommended maximum daily dose equivalent to 400 mg of naproxen base, and in package sizes of the equivalent of 6,000 mg of naproxen base or less

[*220 mg naproxen sodium approximately equivalent to 200 mg naproxen base]

U MAR / 15
Naproxen or its salts..

in preparations containing the equivalent of 200 mg of naproxen base* per oral dosage unit, when sold in products labelled with a recommended maximum daily dose equivalent to 400 mg of naproxen base, and in package sizes exceeding the equivalent of 6,000 mg of naproxen base

[*220 mg naproxen sodium approximately equivalent to 200 mg naproxen base]

III MAR / 15
Naratriptan or its saltsPDL I DEC / 13
Narcotine and its salts Noscapine III SEP / 98
NatalizumabPDL I DEC / 13
Nateglinide or its salts or derivativesPDL I DEC / 13
NecitumumabPDL I APR / 17
Nedocromil or its saltsPDL I DEC / 13
Nefazodone or its saltsPDL I DEC / 13
NelarabinePDL I DEC / 13
Nelfinavir or its saltsPDL I DEC / 13
Neocinchophen or its saltsPDL I DEC / 13
Neomycin or its salts or derivativesPDL

Including but not limited to: Paromomycin sulfate (for veterinary use)

I DEC / 18
Neostigmine saltsPDL I DEC / 13
NepafenacPDL I DEC / 13
Nesiritide or its saltsPDL I DEC / 13
NetupitantPDL I DEC / 17
Nevirapine or its saltsPDL I DEC / 13
Niacin (nicotinic acid)

in extended-release formulations, except when sold in a modified-release oral dosage form that provides 500 milligrams or more per dosage unit or per daily dose

II MAR / 10
Niacin (nicotinic acid).

in immediate-release formulations except when sold in an immediate-release oral dosage form that provides more than 500 milligrams per dosage unit or per daily dose

U MAR / 10
Niacinamide for topical use U OCT / 98
Niacinamide. oral U OCT / 98
Nialamide or its saltsPDL I DEC / 13
NicarbazinPDL

For human use

I DEC / 13
Nicardipine or its saltsPDL I DEC / 13
NicocodineN I JUN / 02
NicomorphineN I JUN / 02
Nicotine and its salts

when sold in the form of a chewing gum containing 4 mg or less of nicotine per dosage unit

U NOV / 00
Nicotine and its salts

when sold in the form of a transdermal patch with a delivery rate of 22 mg or less of nicotine per day

U NOV / 00
Nicotine and its salts

when sold in a form to be administered into the oral cavity by means of a non-active device (one that operates on energy generated by the human body or by gravity) that delivers 4 mg or less of nicotine per dose for buccal absorption;

U JAN / 05
Nicotine and its salts

when sold in the form of a lozenge containing 4 mg or less of nicotine per dosage unit

U JUN / 06
Nicotine or its saltsPDL

For human use, EXCEPT: (a) in natural substances; (b) in the form of a chewing gum containing 4 mg or less of nicotine per dosage unit; (c) in the form of a transdermal patch with a delivery rate of 22 mg or less of nicotine per day; (d) in a form to be administered into the oral cavity by means of a non-active device (one that operates on energy generated by the human body or by gravity) that delivers 4 mg or less of nicotine per dose for buccal absorption; or (e) in the form of a lozenge containing 4 mg or less of nicotine per dosage unit.)

I AUG / 18
Nicotine or its saltsPDL

For veterinary use

I DEC / 13
Nicotinic acidPDL

when sold in: (a) a modified-release oral dosage form that provides 500 milligrams or more per dosage unit or per daily dose; or (b) an immediate-release oral dosage form that provides more than 500 milligrams per dosage unit or per daily dose for human use

I DEC / 13
Nicotinyl-tartrate I SEP / 98
NifedipinePDL I DEC / 13
Nikethamide I SEP / 98
Nilotinib or its saltsPDL I DEC / 13
NilutamidePDL I DEC / 13
NimetazepamTS I JUN / 02
Nimodipine or its saltsPDL I DEC / 13
Nintedanib or its saltsPDL I AUG / 15
NitisinonePDL I NOV / 16
Nitrazepam and its saltsTS I SEP / 98
Nitric oxidePDL I DEC / 13
Nitrofurantoin or its saltsPDL

For human use.

I DEC / 13
Nitroglycerin except for sublingual immediate release dosage forms I SEP / 98
Nitroglycerin. sublingual immediate release dosage forms II SEP / 98
NitroscanatePDL I DEC / 13
NivolumabPDL I JAN / 16
Nizatidine and its saltsNR

when sold in an oral dosage form containing not more than the equivalent of 75 mg of nizatidine*

I SEP / 98
Nizatidine or its saltsPDL

except when sold in an oral dosage form containing not more than the equivalent of 75 mg of nizatidine

I DEC / 13
Nomifensine or its saltsPDL I DEC / 13
NoracymethdolN I JUN / 02
NorboletoneC3 I JUN / 02
NorclostebolC3 I JUN / 02
NorcodeineN I JUN / 02
NordazepamTS I JUN / 02
Norepinephrine and its salts levarterenol, noradrenaline II SEP / 98
NorethandroloneC3 I JUN / 02
NorfloxacinPDL I DEC / 13
NorlevorphanolN I JUN / 02
NormethadoneN I JUN / 02
NormorphineN I JUN / 02
NorpethidineN I JUN / 02
NorpipanoneN I JUN / 02
Nortriptyline or its saltsPDL I DEC / 13
Noscapine III SEP / 98
Novobiocin or its salts and derivativesPDL

For human use.

I DEC / 13
NusinersenPDL I AUG / 17
Nylidrin or its saltsPDL I DEC / 13
Nystatin and its salts and derivatives. in topical preparations for use on the skin III SEP / 98
Nystatin or its salts or derivativesF2

except preparations for topical use on the skin for human use

I DEC / 13
Obeticholic acid or its saltsPDL I MAY / 17
ObinutuzumabPDL I DEC / 14
Oclacitinib or its saltsPDL

including but not limited to Oclacitinib maleate

I AUG / 14
OcrelizumabPDL I SEP / 17
OcriplasminPDL I DEC / 13
Octatropine methylbromidePDL I DEC / 13
OctreotidePDL I DEC / 13
OfatumumabPDL I DEC / 13
Ofloxacin or its saltsPDL

including but not limited to levofloxacin

I DEC / 13
Olanzapine or its saltsPDL I DEC / 13
OlaparibPDL I AUG / 16
OlaratumabPDL I MAR / 18
Oleandomycin or its salts or derivativesPDL

For human use.

I DEC / 13
Olmesartan and its salts and derivativesPDL

including but not limited to olmesartan medoxmil

I DEC / 13
Olodaterol or its saltsPDL I DEC / 13
Olopatadine or its saltsPDL I DEC / 13
Olsalazine or its saltsPDL I DEC / 13
OmalizumabPDL I DEC / 13
OmbitasvirPDL I MAR / 15
Omeprazole or its saltsPDL

including but not limited to omeprazole, omeprazole magnesium except when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole for human use

I SEP / 14
Omeprazole or its saltsPDL

For veterinary use including but not limited to omeprazole, omeprazole magnesium

I DEC / 13
Omeprazole or its salts.

when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole

II SEP / 14
Ondansetron or its saltsPDL I DEC / 13
OpiumN I JUN / 02
Orbifloxacin or its salts or derivativesPDL I DEC / 13
Orciprenaline (Metaproterenol) or its saltsPDL I DEC / 13
OrlistatPDL I DEC / 13
Ormetoprim or its saltsPDL I DEC / 13
OrnidazolePDL I DEC / 13
Orphenadrine citrate III SEP / 98
Orphenadrine hydrochloride I SEP / 98
Oseltamivir or its saltsPDL I DEC / 13
Osimertinib or its saltsPDL I AUG / 16
Oxabolone and its derivativesC3 I SEP / 98
Oxacillin, or its salts or derivativesPDL

For veterinary use

I DEC / 13
OxaliplatinPDL I DEC / 13
OxanamidePDL I DEC / 13
OxandroloneC3 I JUN / 02
Oxaprozin or its salts or derivativesPDL I DEC / 13
Oxazepam and its saltsTS I SEP / 98
OxazolamTS I JUN / 02
OxcarbazepinePDL I DEC / 13
Oxethazine III SEP / 98
Oxiconazole 1% for topical use U SEP / 99
Oxolinic acid or its saltsPDL I DEC / 13
Oxprenolol or its saltsPDL I DEC / 13
Oxybuprocaine and its salts benoxinate for opthalmic or parenteral use II SEP / 98
Oxybuprocaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Oxybutynin or its saltsPDL I DEC / 13
OxycodoneN I JUN / 02
OxymesteroneC3 I JUN / 02
Oxymetazoline in nasal preparations for adult use and in ophthalmic products U
Oxymetazoline and its salts in nasal preparations for pediatric use II SEP / 98
OxymetholoneC3 I JUN / 02
OxymorphoneN I JUN / 02
Oxyphenbutazone or its saltsPDL I DEC / 13
Oxyquinoline II SEP / 98
Oxytetracycline or its saltsPDL

For veterinary use
 

I DEC / 18
OxytocinPDL I DEC / 13
Ozenoxacin or its saltsPDL I JUN / 17
Paclitaxel or its derivativesPDL I DEC / 13
Palbociclib or its saltsPDL I AUG / 16
PaliferminPDL I DEC / 13
Paliperidone or its salts and its derivativesPDL I DEC / 13
PalivizumabPDL I DEC / 13
Palonosetron or its saltsPDL

including but not limited to palonosetron hydrochloride

I DEC / 13
Pamidronic acid and its saltsPDL I DEC / 13
Pancreatic extractsPDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancreatic extracts, pancreatin, pancrelipase except when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency U DEC / 13
PancreatinPDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
PancrelipasePDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancuronium and its saltsPDL I DEC / 13
PanitumumabPDL I DEC / 13
Pantoprazole and its saltsPDL I DEC / 13
Papain as a debriding agent U SEP / 99
Papaveretrine or its salts I SEP / 98
Papaverine or its salts I SEP / 98
ParaldehydePDL I DEC / 13
ParamethadionePDL I DEC / 13
Pargyline and its saltsPDL I DEC / 13
ParicalcitolPDL I DEC / 13
Paritaprevir (Veruprevir)PDL I MAR / 15
Paroxetine or its saltsPDL I DEC / 13
Paroxypropione II SEP / 98
Pasireotide or its saltsPDL I DEC / 13
Patiromer sorbitex calciumPDL I NOV / 18
Patisiran or its saltsPDL I JUL / 19
Pazopanib or its saltsPDL I DEC / 13
Pegaptanib and its saltsPDL I DEC / 13
PegaspargasePDL I APR / 17
PegfilgrastimPDL I DEC / 13
PegvisomantPDL I DEC / 13
PembrolizumabPDL I JUN / 15
Pemetrexed or its saltsPDL I DEC / 13
Pemoline and any salts thereofC4 I JAN / 03
Penciclovir or its saltsPDL I DEC / 13
PenicillaminePDL I DEC / 13
Penicillin or its salts or derivativesPDL

Including but not limited to:
Amoxicillin, ampicillin, azlocillin, benzathine penicillin, carbenicillin, cloxacillin, dicloxacillin, hetacillin, mecillinam, methicillin, mezlocillin, nafcillin, oxacillin, ticarcillin, penicillin G (benzyl penicillin), procaine penicillin G
 

I DEC / 18
Pentaerythritol tetranitrate I SEP / 98
Pentagastrin and its salts II SEP / 98
Pentamidine and its saltsPDL I DEC / 13
PentazocineN I JUN / 02
PentobarbitalC1 I JUN / 02
Pentolinium tartratePDL I DEC / 13
Pentosan polysulfate or its saltsPDL I DEC / 13
Pentostatin or its saltsPDL I DEC / 13
Pentoxifylline or its saltsPDL I DEC / 13
Pepsin U
Peptone U
Peramivir or its salts or derivativesPDL I MAR / 17
PerampanelPDL I DEC / 13
PerflutrenPDL I DEC / 13
Pergolide or its saltsPDL I DEC / 13
Pericyazine or its saltsPDL I DEC / 13
Perindopril or its saltsPDL I DEC / 13
Permethrin and its derivatives II SEP / 98
Permethrin or its derivativesPDL I DEC / 13
Perphenazine or its saltsPDL I DEC / 13
Pertussis vaccine II DEC / 98
PertuzumabPDL I DEC / 13
PethidineN I JUN / 02
Pethidine Intermediate CN I JUN / 02
Phacetoperane and its saltsPDL I DEC / 13
PhenacemidePDL I DEC / 13
PhenacetinPDL I DEC / 13
PhenadoxoneN I JUN / 02
PhenaglycodolPDL I DEC / 13
PhenampromideN I JUN / 02
PhenazocineN I JUN / 02
Phenazopyridine and its saltsPDL I DEC / 13
PhencyclidineN I JUN / 02
Phendimetrazine and any salt thereofC1 I JUN / 02
Phenelzine or its saltsPDL I DEC / 13
Phenformin and its saltsPDL I DEC / 13
Pheniprazine or its saltsPDL I DEC / 13
Pheniramine U
Phenmetrazine and any salt thereofC1 I JUN / 02
PhenobarbitalC2 I JUN / 02
Phenol preparations with concentration of more than 20% II SEP / 98
PhenomorphanN I JUN / 02
PhenoperidineN I JUN / 02
Phenoxybenzamine and its salts II SEP / 98
Phentermine and any salt thereofC2 I JUN / 02
Phenthoxate or its saltsPDL I DEC / 13
Phentolamine or its saltsPDL I DEC / 13
Phenylbutazone or its saltsPDL I DEC / 13
Phenylbutyric acid or its salts or derivativesPDL

including but not limited to glycerol phenylbutyrate, phenylbutyrate sodium

I AUG / 16
Phenylephrine and its salts and preparations in nasal preparations in concentrations of 2.5% or less, for pediatric use II SEP / 98
Phenylephrine and its salts and preparations. for oral use, in nasal preparations for adults and in ophthalmic preparations in concentrations of 2.5% or less U
Phenylephrine or its saltsF1

in preparations for parenteral use or ophthalmic use in concentrations greater than 2.5%

I DEC / 13
Phenylindanedione or its derivativesPDL I DEC / 13
Phenylmethylbarbituric AcidC2 I JUN / 02
Phenylpropanolamine or its salts or derivativesPDL I DEC / 13
Phenyltoloxamine and its salts III SEP / 98
PholcodineN I JUN / 02
Physostigmine salicylatePDL

except preparations for oral or topical use only for human use

I DEC / 13
Physostigmine salicylate.

for oral or topical use

II SEP / 98
Phytocannabinoids produced by, or found in, the cannabis plant and substances that are duplicates of such phytocannabinoids.*PDL

except:
1) derivatives of cannabis as defined in subsection 2(1) of the Cannabis Act that are exempt from the application of the Cannabis Act under the Industrial Hemp Regulations and that do not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid, or

2) anything referred to in Schedule 2 to the Cannabis Act that contains no more than 10 µg/g delta-9-tetrahydrocannabinol and that does not contain an isolated or concentrated phytocannabinoid or a synthetic duplicate of that phytocannabinoid.

*Note: this listing is copied from the Health Canada Prescription Drug List and applies to products that have received a Notice of Compliance and Drug Identification Number and been classified as prescription drugs by Health Canada. Cannabis products, as defined in the Cannabis Act and its regulations, are not granted a Notice of Compliance and Drug Identification Number by Health Canada and are considered outside the scope of the National Drug Schedules.

I OCT / 18
PibrentasvirPDL I SEP / 17
Pilocarpine or its saltsPDL I DEC / 13
PimecrolimusPDL I DEC / 13
PiminodineN I JUN / 02
PimobendanPDL I DEC / 13
PimozidePDL I DEC / 13
Pinaverium bromidePDL I DEC / 13
PinazepamTS I JUN / 02
Pindolol or its saltsPDL I DEC / 13
Pioglitazone or its saltsPDL I DEC / 13
Pipecuronium bromidePDL I DEC / 13
Piperacetazine or its saltsPDL I DEC / 13
Piperazine and its salts II SEP / 98
Piperilate or its saltsPDL I DEC / 13
PipobromanPDL I DEC / 13
Pipotiazine or its saltsPDL I DEC / 13
Pipradol and any salt thereofTS I SEP / 98
Pirbuterol or its saltsPDL I DEC / 13
Pirenzepine or its saltsPDL I DEC / 13
Pirfenidone or its derivativesPDL I DEC / 13
Pirlimycin or its saltsPDL I DEC / 13
Piroxicam or its saltsPDL I DEC / 13
Pizotyline or its saltsPDL I DEC / 13
Plerixafor or its saltsPDL I DEC / 13
Pneumococcal 7-valent conjugate vaccine II JAN / 04
Pneumococcal polysaccharide vaccines II FEB / 02
PodophyllotoxinPDL

when recommended for topical use

I DEC / 13
PolidocanolPDL

when indicated for administration by injection

I JAN / 16
Poliomyelitis vaccine II DEC / 98
Polyacrylamide II SEP / 98
Polyethylene glycol topical administration U
Polyethylene glycol 3350 as a single ingredient oral product indicated as a laxative to treat occasional constipation U JUL / 10
Polymyxin B or its salts or derivativesPDL

for human use, except for topical use or for local action in the oral cavity or nasal passages

I DEC / 13
Polymyxin B or its salts or derivatives.PDL

for veterinary use, when sold in combination with other medicinal ingredients

I APR / 16
Polymyxin B or its salts or derivatives..

for human, ophthalmic use

III JUN / 06
Polymyxin or its salts or derivatives for human, topical use U
Polysulfated glycosaminoglycanPDL I DEC / 13
Pomalidomide or its saltsPDL I FEB / 14
Ponatinib or its saltsPDL I MAY / 15
Poractant alfaPDL I DEC / 13
Porfimer or its saltsPDL I DEC / 13
PosaconazolePDL I DEC / 13
Potassium bromidePDL I DEC / 13
Potassium citratePDL

when recommended for the treatment of renal tubular acidosis and kidney stones

I DEC / 13
Potassium gluconatePDL

for veterinary use, when sold or recommended for administration to cats

I DEC / 13
Potassium para-aminobenzoatePDL

except in preparations for topical use on the skin

I DEC / 13
Potassium salts in preparations for injection I DEC / 99
Potassium salts. in oral preparations containing more than 5 mmol per single dose [except potassium bromide, potassium gluconate when sold or recommended for administration to cats, potassium para-aminobenzoate, potassium citrate when recommended for the treatment of renal tubular acidosis and kidney stones] II DEC / 13
Povidone - iodine vaginal preparations, except in concentrations of 5% or less II SEP / 98
Povidone - iodine topical preparations, except in concentrations of 5% or less III SEP / 98
Pradofloxacin or their salts or derivativesPDL I MAR / 15
Pralatrexate or its saltsPDL I DEC / 18
Pralidoxime or its saltsPDL I DEC / 13
Pramipexole or its saltsPDL I DEC / 13
Pramoxine and its salts for ophthalmic or parenteral use II SEP / 98
Pramoxine and its salts.

for topical use on mucous membranes, except lozenges

III SEP / 98
Pramoxine and its salts.. for topical application on the skin, and including lozenges U DEC / 05
PrasteroneC3 I JUN / 02
Prasugrel or its saltsPDL I DEC / 13
Pravastatin or its saltsPDL I DEC / 13
Prazepam and its saltsTS I SEP / 98
PraziquantelPDL I DEC / 13
PraziquantelPDL

For veterinary use - Except when sold for the treatment of the tapeworm Anoplocephala perfoliata in horses

I DEC / 13
Prazosin or its saltsPDL I DEC / 13
Pregabalin or its salts or derivativesPDL I DEC / 13
Prenylamine or its saltsPDL I DEC / 13
Prilocaine and its salts

for ophthalmic or parenteral use

II SEP / 98
Prilocaine and its salts.

for topical use on mucous membranes, except lozenges

III SEP / 98
Primaquine or its saltsPDL I DEC / 13
PrimidonePDL

for human use

I DEC / 13
ProbarbitalC2 I JUN / 02
Probenecid or its saltsPDL I DEC / 13
ProbucolPDL I DEC / 13
Procainamide or its saltsPDL I DEC / 13
Procaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Procaine and its salts for ophthalmic or parenteral use II SEP / 98
Procarbazine or its saltsPDL I DEC / 13
Procaterol or its saltsPDL I DEC / 13
Prochlorperazine or its saltsPDL I DEC / 13
Procyclidine or its saltsPDL I DEC / 13
Prodilidine or its saltsPDL I DEC / 13
Profenamine or its saltsPDL

including but not limited to ethopropazine

I DEC / 13
Progesterone or its derivativesPDL

For veterinary use - Except when recommended for use in progesterone implants indicated for growth promotion, melengestrol acetate in feed for the suppression of estrus in beef heifers

I DEC / 13
Proguanil or its saltsPDL I DEC / 13
ProheptazineN I JUN / 02
Promazine or its saltsPDL

for human use

I DEC / 13
Promethazine and its salts except for topical use II SEP / 98
Promethazine and its salts for topical use III SEP / 98
Propafenone or its saltsPDL I DEC / 13
PropallylonalC2 I JUN / 02
Propantheline and its salts II SEP / 98
Proparacaine and its salts for ophthalmic or parenteral use II SEP / 98
Proparacaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
ProperidineN I JUN / 02
PropiramN I JUN / 02
Propiverine or its saltsPDL I MAR / 17
PropofolPDL I DEC / 13
Propranolol or its saltsPDL I DEC / 13
Propylene glycol topical application U
Propylhexedrine II SEP / 98
Proquamezine [aminopromazine] and its salts for internal use I SEP / 98
Prostaglandins or their salts or derivatives or analoguesPDL

Including but not limited to: Alprostadil, bimatoprost, cloprostenol, dinoprostone, epoprostenol, fluprostenol, latanoprost, latanoprostene bunod, lubiprostone, misoprostol, tafluprost, travoprost, treprostinil, unoprostone

I AUG / 15
Protamine and its salts II SEP / 98
Prothipendyl hydrochloridePDL I DEC / 13
ProtirelinPDL I DEC / 13
Protriptyline or its saltsPDL I DEC / 13
Prucalopride or its saltsPDL

including but not limited to prucalopride succinate

I DEC / 13
Pseudoephedrine and its salts and preparations in combination products Note: Pharmacists are advised that in areas where there is evidence of abuse or particular concern about abuse, pseudoephedrine products should not be located in a self-selection area of the pharmacy III APR / 06
Pseudoephedrine and its salts and preparations in single entity products II APR / 06
Pyrantel and its salts II SEP / 98
PyrazinamidePDL I DEC / 13
Pyrethrins II SEP / 98
Pyrethrins/piperonyl butoxide II SEP / 98
Pyridostigmine bromidePDL I DEC / 13
Pyrilamine U
Pyrimethamine or its saltsPDL I DEC / 13
Pyrovalerone and any salt thereofC4 I JAN / 03
Pyrvinium and its salts II SEP / 98
QuazepamTS I JUN / 02
Quetiapine or its saltsPDL I DEC / 13
Quinagolide or its saltsPDL I DEC / 13
Quinapril or its salts or derivativesPDL I DEC / 13
QuinboloneC3 I JUN / 02
Quinidine salts I SEP / 98
Quinine or its salts or derivativesPDL

except when sold in oral dosage form that provides 50 mg or less of quinine base per dosage unit or per daily dose

I DEC / 13
Quinupristin or its saltsPDL I DEC / 13
Rabeprazole or its saltsPDL I DEC / 13
Rabies immune globulin I FEB / 02
Rabies vaccine I FEB / 02
Racemethionine II SEP / 98
RacemethorphanN I JUN / 02
RacemoramideN I JUN / 02
RacemorphanN I JUN / 02
Raloxifene or its saltsPDL I DEC / 13
Raltegravir or its saltsPDL I DEC / 13
Raltitrexed or its salts or derivativesPDL

including but not limited to raltitrexed disodium

I DEC / 13
Ramipril or its salts or derivativesPDL I DEC / 13
RamucirumabPDL I OCT / 15
RanibizumabPDL I DEC / 13
Ranitidine or its saltsPDL

except when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn for human use

I DEC / 13
Ranitidine or its salts. when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 4,500 mg of ranitidine III MAR / 08
Ranitidine or its salts.. when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing no more than 4,500 mg of ranitidine U FEB / 07
Rasagiline or its saltsPDL I DEC / 13
RasburicasePDL I DEC / 13
Raubasine or its saltsPDL I DEC / 13
RauwolfiaPDL I DEC / 13
Regorafenib or its saltsPDL I DEC / 13
Remestemcel-LPDL I DEC / 13
RemifentanilN I JUN / 02
Remoxipride or its saltsPDL I DEC / 12
Repaglinide or its salts or derivativesPDL I DEC / 13
Rescinnamine or its saltsPDL I DEC / 13
Reserpine or its saltsPDL

for human use

I DEC / 13
ReslizumabPDL I JUN / 17
Resocortol and its derivatives.FR AUG / 06
Resocortol or its derivativesPDL I DEC / 13
RetapamulinPDL I DEC / 13
Reviparin or its saltsPDL I DEC / 13
Rho D immune globulin I FEB / 02
RibavirinPDL I DEC / 13
Ribociclib or its saltsPDL I MAY / 18
Ricoiguat or its derivativesPDL I DEC / 13
Rifabutin or its saltsPDL I DEC / 13
Rifampin or its salts or derivativesPDL I DEC / 13
Rifaximin or its salts or derivativesPDL I DEC / 13
Rilpivirine or its salts or derivativesPDL

including but not limited to rilpivirine hydrochloride

I DEC / 13
Riluzole or its saltsPDL I DEC / 13
RisankizumabPDL I JUL / 19
Risedronic acid or its saltsPDL I DEC / 13
Risperidone or its saltsPDL I DEC / 13
Ritodrine and its saltsPDL I DEC / 13
RitonavirPDL I DEC / 13
RituximabPDL I DEC / 13
RivaroxabanPDL I DEC / 13
Rivastigmine or its saltsPDL I DEC / 13
Rizatriptan or its saltsPDL I DEC / 13
Rocuronium bromidePDL I DEC / 13
RofecoxibPDL I DEC / 13
Roflumilast or its salts or derivativesPDL I DEC / 13
RomidepsinPDL I DEC / 13
Romifidine or its saltsPDL I DEC / 13
RomiplostimPDL I DEC / 13
Ronidazole or its salts or derivativesPDL

for human use

I DEC / 13
Ropinirole or its saltsPDL I DEC / 13
Rose Bengal II SEP / 98
Rosiglitazone or its saltsPDL I DEC / 13
Rosoxacin or its saltsPDL I DEC / 13
Rosuvastatin or its saltsPDL I DEC / 13
Rotigotine or its salts or derivativesPDL I DEC / 13
Rubella vaccine II DEC / 98
Rue and its preparations and extracts II SEP / 98
Rufinamide or its derivativesPDL I DEC / 13
Rupatadine or its saltsPDL I FEB / 17
Ruxolitinib or its saltsPDL

including but not limited to ruxolitinib phosphate

I DEC / 13
Sacubitril or its saltsPDL I JAN / 16
Safinamide or its saltsPDL I FEB / 19
Salbutamol or its saltsPDL I DEC / 13
Salicylic acidPDL

when sold in topical formulations containing salicylic acid at concentrations greater than 20% and/or with a pH less than 3.0, except when sold to be applied to warts, corns or calluses

I DEC / 14
Salicylic acid and its salts when sold to be applied to warts, corns or calluses in topical preparations in concentrations greater than 40% II DEC / 14
Salicylic acid and its salts.

in topical preparations in concentrations up to and including 40% (except when sold in topical formulations containing salicylic acid at concentrations greater than 20% and/or with a pH less than 3.0 for a use other than to be applied to warts, corns and calluses)

U DEC / 14
Salmeterol or its saltsPDL I DEC / 13
Salsalate or its salts or derivativesPDL I DEC / 13
Sapropterin or its saltsPDL I DEC / 13
Saquinavir or its salts or derivativesPDL I DEC / 13
Saralasin or its saltsPDL I DEC / 13
SargramostimPDL I DEC / 13
SarilumabPDL I MAR / 17
SarolanerPDL

for veterinary use

I AUG / 16
Saxagliptin or its saltsPDL I DEC / 13
Scopolamine and its salts hyoscine, except Hyoscine butylbromide, when recommended for parenteral use II AUG / 16
Sebelipase alfaPDL I MAR / 18
SecobarbitalC1 I JUN / 02
SecukinumabPDL I MAY / 15
Selegiline or its saltsPDL I DEC / 13
Selenium in injectable form for parenteral nutrition I JAN / 03
SemaglutidePDL I MAR / 18
Senna and its extracts and derivatives U
Sermorelin or its saltsPDL I DEC / 13
Sertraline or its saltsPDL I DEC / 13
Sevelamer or its saltsPDL I DEC / 13
SevofluranePDL I DEC / 13
Sex hormones (natural or synthetic)PDL

for human use, including but not limited to conjugated estrogens, desogestrel, dienogest, estradiol benzoate, estradiol(hemihydrate), estrone, ethinyl estradiol, ethynodiol diacetate, etonogestrel, levonorgestrel, medroxyprogesterone acetate, norelgestromin, norethindrone acetate, norgestimate, progesterone except the following: androisoxazole, androstanolone, androstenediol or its derivatives, bolandiol or its derivatives, bolasterone, bolazine, boldenone or its derivatives, bolenol, calusterone, clostebol or its derivatives, drostanolone or its derivatives, enestebol, epitiostanol, ethylestrenol, fluoxymesterone, formebolone, furazabol, 4-Hydroxy-19-nortestosterone or its derivatives, levonorgestrel when sold as a single ingredient in an oral dosage form containing no more than 1.5 milligrams, mebolazine,mesabolone, mesterolone, metandienone, metenolone or its derivatives, methandriol, methyltestosterone or its derivatives, metribolone, mibolerone, nandrolone or its derivatives, norboletone, norclostebol or its derivatives, norethandrolone, oxabolone or its derivatives, oxandrolone, oxymesterone, oxymetholone, prasterone, quinbolone, stanozolol, stenbolone or its derivatives, testosterone or its derivatives, tibolone, tiomesterone, trenbolone or its derivatives, zeranol

I AUG / 15
Sibutramine or its saltsPDL I DEC / 13
SigmodalC2 I JUN / 02
Sildenafil or its saltsPDL I DEC / 13
Silodosin or its salts or derivativesPDL I DEC / 13
SiltuximabPDL I DEC / 14
Silver nitrate II SEP / 98
Simeprevir or its saltsPDL I DEC / 13
SimvastatinPDL I DEC / 13
Sincalide II SEP / 98
Sirolimus or its derivativesPDL

including but not limited to everolimus, temsirolimus

I DEC / 13
Sitagliptin or its saltsPDL I DEC / 13
Sitaxentan or its saltsPDL I DEC / 13
Sodium acetate for parenteral use II SEP / 98
Sodium acetate in injectable form for parenteral nutrition I JAN / 03
Sodium biphosphate

for parenteral use

II SEP / 98
Sodium biphosphate.

cathartics

III SEP / 98
Sodium bromidePDL I DEC / 13
Sodium chloride single ingredient solutions for parenteral or ophthalmic use in concentrations of more than 0.9% [NOTE: Does not apply to contact lens solutions intended to be rinsed off prior to insertion into eye] II OCT / 98
Sodium chloride in injectable form for parenteral nutrition I JAN / 03
Sodium citrate for parenteral use II SEP / 98
Sodium cromoglicate (cromoglycate) in solutions in concentrations of 2% or less for ophthalmic or nasal use III SEP / 98
Sodium fluoride (see Fluoride)PDL

in solid oral dosage forms containing more than 1 mg of fluoride ion for human use

I DEC / 13
Sodium iodide for sclerosing II SEP / 98
Sodium iodine in injectable form for parenteral nutrition I JAN / 03
Sodium nitritePDL

when indicated for administration by injection and sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning

I JUN / 15
Sodium nitroprusside or its saltsPDL I DEC / 13
Sodium phosphate for parenteral use II SEP / 98
Sodium phosphate in injectable form for parenteral nutrition I JAN / 03
Sodium phosphate. cathartics III SEP / 98
Sodium picosulphate

for oral purgatives, 10 mg per pack (when found in preparations with magnesium oxide 3.5 g and citric acid 12 g)

II JAN / 10
Sodium polystyrene sulfonatePDL I DEC / 13
Sodium tartrate U
Sodium tetradecylsulfate II SEP / 98
Sofosbuvir or its saltsPDL I FEB / 14
Solifenacin or its saltsPDL I DEC / 13
SomatostatinPDL I DEC / 13
SomatremPDL I DEC / 13
SomatropinPDL I DEC / 13
Sorafenib and its saltsF1 I APR / 08
Sotalol and its saltsF1 I SEP / 98
Spectinomycin or its salts or derivativesPDL I DEC / 18
Spiramycin and its salts and derivativesF2 I SEP / 98
SpironolactonePDL I DEC / 13
StanozololC3 I JUN / 02
StavudinePDL I DEC / 13
StenboloneC3 I JUN / 02
StiripentolPDL I DEC / 13
Stramonium, its preparations, extracts and compounds II SEP / 98
Streptokinase as a debriding agent II SEP / 98
Streptokinase/streptodornase I SEP / 98
Streptomycin or its salts or derivativesPDL

For human use

I DEC / 18
Streptomycin or its salts or derivativesPDL

For veterinary use, including but not limited to dihydrostreptomycin

I DEC / 18
StreptozocinPDL I DEC / 13
Strontium and its salts for parenteral use II SEP / 98
Strontium bromidePDL I DEC / 13
Succinimide or its salts or derivativesPDL

except those compounds used for decontaminating water including but not limited to methsuximide 

I DEC / 13
Succinylcholine and its saltsF1 I SEP / 98
SucralfateF1 I SEP / 98
Sucroferric oxyhydroxidePDL I MAY / 18
SufentanilN I JUN / 02
Sugammadex or its saltsPDL I AUG / 16
Sulconazole or its saltsPDL I DEC / 13
Sulfinpyrazone or its saltsPDL I DEC / 13
Sulindac or its saltsPDL I DEC / 13
Sulphonamides or their salts or derivativesPDL

Including but not limited to Brinzolamide, succinylsulfathiazole, sulfacetamide, sulfadiazine, sulfadimethoxine, sulfadoxine, sulfaguanidine, sulfamerazine, sulfamethazine, sulfamethoxazole, sulfanilamide, sulfapyridine, sulfaquinoxaline, sulfasalazine, sulfathiazole, sulfisoxazole, sulphanilamide

I DEC / 18
Sulphones or their derivativesPDL

Including but not limited to dapsone 

I DEC / 13
Sumatriptan or its saltsPDL I DEC / 13
Sunitinib or its saltsPDL I DEC / 13
Suprofen or its saltsPDL I DEC / 13
Sutilains II SEP / 98
SuvorexantPDL I DEC / 18
Suxamethonium chloridePDL I DEC / 13
Synthetic cannabinoid receptor type-1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomersN

as listed in the schedules to the Controlled Drugs and Substances Act and the Narcotic Control Regulations

I JUL / 15
Tacrolimus or its derivativesPDL I DEC / 13
Tadalafil or its saltsPDL I DEC / 13
TalbutalC2 I JUN / 02
Taliglucerase alfaPDL I JUN / 14
Tamoxifen or its saltsPDL I DEC / 13
Tamsulosin or its saltsPDL I DEC / 13
TapentadolN (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers I JAN / 16
TazarotenePDL I DEC / 13
Tazobactam or its salts or derivativesPDL I DEC / 13
Tedizolid or its salts or derivativesPDL

including but not limited to Tedizolid phosphate

I MAY / 15
TeduglutidePDL I OCT / 15
TeflubenzuronPDL I DEC / 13
Tegaserod or its saltsPDL I DEC / 13
Telaprevir or its derivativesPDL I DEC / 13
TelbivudinePDL I DEC / 13
Telmisartan or its salts or derivativesPDL I DEC / 13
Telotristat or its salts or derivativesPDL I NOV / 18
Temazepam and its saltsTS I SEP / 98
Temozolomide or its saltsPDL I DEC / 13
TeniposidePDL I DEC / 13
Tenofovir or its salts or derivativesPDL

Including but not limited to: tenofovir disoproxil, tenofovir alafenamide

I DEC / 13
Tenoxicam or its saltsPDL I DEC / 13
Tepoxalin or its derivativesPDL I DEC / 13
Terazosin or its saltsPDL I DEC / 13
Terbinafine or its saltsPDL I DEC / 13
Terbutaline or its saltsPDL I DEC / 13
Terconazole or its saltsPDL I DEC / 13
Terfenadine or its saltsPDL I DEC / 13
Teriparatide or its saltsPDL I DEC / 13
Terlipressin or its saltsPDL I DEC / 13
Tesamorelin or its salts or derivativesPDL I APR / 14
TestosteroneC3 I JUN / 02
Tetanus immune globulin I FEB / 02
Tetanus toxoid II DEC / 98
Tetrabenazine or its saltsPDL I DEC / 13
TetracainePDL

when in a preparation containing an equal amount of lidocaine and recommended for topical use on the skin, in concentrations of 7% or higher

I FEB / 14
Tetracaine and its salts

for ophthalmic or parenteral use

II SEP / 98
Tetracaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Tetracycline or its salts or derivativesPDL I DEC / 18
Tetrahydrozoline in nasal preparations for pediatric use II SEP / 98
Tetrahydrozoline. for ophthalmic use and in nasal preparations for adults U
TetrazepamTS I JUN / 02
Tezacaftor or its saltsPDL I JUL / 18
ThalidomidePDL I DEC / 13
ThebaconN I JUN / 02
Thebaine (paramorphine)N I JUN / 02
Theophylline or its saltsPDL I DEC / 13
ThiabendazolePDL

For human use

I DEC / 13
ThialbarbitalC2 I JUN / 02
ThiamylalC2 I JUN / 02
Thiethylperazine or its saltsPDL I DEC / 13
Thiobarbituric AcidC2 I JUN / 02
ThiocarlidePDL I DEC / 13
ThiofentanylN I JUN / 02
ThioguaninePDL I DEC / 13
ThiopentalC2 I JUN / 02
Thiopropazate or its saltsPDL I DEC / 13
Thioproperazine or its saltsPDL I DEC / 13
Thioridazine or its saltsPDL I DEC / 13
ThiotepaPDL I DEC / 13
Thiothixene or its saltsPDL I DEC / 13
Thiouracil or its derivativesPDL I DEC / 13
Thrombin II SEP / 98
Thyroglobulin II SEP / 98
ThyroidPDL

For human use

I DEC / 13
Thyrotropin II SEP / 98
Thyrotropin alfaPDL I DEC / 13
Thyroxin or its saltsPDL

Including but not limited to Levothyroxine sodium

I DEC / 13
Tiamulin or its saltsPDL

For veterinary use, including but not limited to: Tiamulin fumarate

I DEC / 18
Tiaprofenic acid or its saltsPDL I DEC / 13
TiboloneC3 I JUN / 02
Ticagrelor or its derivativesPDL I DEC / 13
Ticarcillin or its salts or derivativesPDL

For veterinary use

I DEC / 13
Ticlopidine or its saltsPDL I DEC / 13
TigecyclinePDL I DEC / 13
Tilidine and its salts, derivatives and salts of derivativesN I JUN / 02
Tiludronic acid or its saltsPDL I DEC / 13
Timolol or its saltsPDL I DEC / 13
TinidazolePDL I DEC / 13
Tinzaparin or its saltsPDL I DEC / 13
Tioconazole and its salts.. in preparations for intra-vaginal use III OCT / 98
Tioconazole and its salts... in preparations for topical use U OCT / 98
Tioconazole or its saltsPDL

For human use, except in preparations for topical or vaginal use 

I DEC / 13
TiomesteroneC3 I JUN / 02
Tiotropium bromidePDL I DEC / 13
Tipiracil or its saltsPDL I MAR / 18
Tipranavir or its saltsPDL I DEC / 13
Tirofiban or its salts or derivativesPDL I DEC / 13
TisagenlecleucelPDL I OCT / 18
Tizanidine or its saltsPDL I DEC / 13
Tobramycin or its salts or derivativesPDL I DEC / 13
Tocainide or its saltsPDL I DEC / 13
Toceranib or its saltsPDL I DEC / 13
TocilizumabPDL I DEC / 13
Tofacitinib or its saltsPDL I APR / 14
TolazamidePDL I DEC / 13
Tolazoline or its saltsPDL I DEC / 13
TolbutamidePDL I DEC / 13
TolcaponePDL I DEC / 13
Tolfenamic acid or its salts or derivativesPDL I DEC / 13
Tolmetin or its saltsPDL I DEC / 13
Tolterodine or its saltsF1 I DEC / 13
Toltrazuril or its salts or derivativesPDL

Including but not limited to Ponazuril 

I DEC / 13
Tolvaptan or its derivativesPDL I DEC / 13
TopiramatePDL I DEC / 13
Topotecan or its saltsF1 I DEC / 13
Torasemide or its saltsPDL I DEC / 13
Toremifene or its saltsPDL I DEC / 13
Trabectedin or its salts or derivativesPDL I DEC / 13
Tramadol or its saltsPDL I DEC / 13
Trametinib or its salts or derivativesPDL I DEC / 13
Trandolapril or its salts or derivativesPDL I DEC / 13
Tranexamic acidPDL I DEC / 13
TranylcyprominePDL I DEC / 13
TrastuzumabPDL I DEC / 13
Trastuzumab emtansinePDL I DEC / 13
Trazodone or its saltsPDL I DEC / 13
TrenboloneC3 I JUN / 02
TreosulfanPDL I DEC / 13
TretaminePDL I DEC / 13
Tretinoin or its salts or derivativesPDL I DEC / 13
Triamcinolone acetonide

in an aqueous nasal spray that delivers 55 mcg per metered spray for adults and children 12 years of age and older, in package sizes containing more than 120 metered sprays

II JAN / 15
Triamcinolone acetonide.

in an aqueous nasal spray that delivers 55 mcg per metered spray for adults and children 12 years of age and older, in package sizes containing no more than 120 metered sprays

III JAN / 15
Triamterene or its saltsPDL I DEC / 13
Triazolam and its saltsTS I SEP / 98
Tricaine or its saltsPDL I DEC / 13
Triethanolamine oleate III SEP / 98
Triethanolamine salicylate in concentrations greater than 20% III SEP / 98
Triethanolamine salicylate. in concentrations up to and including 20% U
Trifluoperazine or its saltsPDL I DEC / 13
Triflupromazine or its saltsPDL I DEC / 13
TrifluridinePDL I DEC / 13
Trihexyphenidyl or its saltsPDL I DEC / 13
Triiodothyropropionic acidPDL I DEC / 13
TrilostanePDL I DEC / 13
Trimebutine or its saltsPDL I DEC / 13
TrimeperidineN I JUN / 02
Trimeprazine or its saltsPDL

for human use

I DEC / 13
TrimethadionePDL I DEC / 13
Trimethaphan camsylatePDL I DEC / 13
Trimethoprim or its saltsPDL I DEC / 13
Trimetrexate or its saltsPDL I DEC / 13
Trimipramine or its saltsPDL I DEC / 13
TrioxsalenPDL I DEC / 13
Tripelennamine and its salts III SEP / 98
Triprolidine III SEP / 98
Triptorelin or its salts or derivativesPDL I DEC / 13
TroglitazonePDL I DEC / 13
Tropicamide or its saltsPDL

in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada for human use

I DEC / 13
Tropicamide or its saltsPDL

For veterinary use

I DEC / 13
Trospium chloridePDL I DEC / 13
Trovafloxacin or its salts or derivativesPDL

including but not limited to alatrofloxacin

I DEC / 13
Trypsin U DEC / 98
Tubocurarine chloridePDL I DEC / 13
TulathromycinPDL

For veterinary use

I DEC / 13
TybamatePDL I DEC / 13
Tylosin or its salts or derivativesPDL

Including but not limited to: Tildipirosin, tilmicosin, tylvalosin

I DEC / 18
Typhoid vaccines/Salmonella Typhi vaccines I FEB / 02
Tyrothricine III SEP / 98
Ubiquinone U DEC / 98
Ulipristal or its salts or derivativesPDL I DEC / 13
Umeclidinium or its salts or derivativesPDL I FEB / 14
Uracil and its saltsF1 when sold for the treatment of cancer I DEC / 11
Uracil mustard or its saltsPDL I DEC / 13
Urea in topical preparations in concentrations of more than 25% II SEP / 98
UrokinasePDL I DEC / 13
Ursodeoxycholic acid or its saltsPDL I DEC / 13
UstekinumabPDL I DEC / 13
Vaccines (except for - those which are part of a routine immunization program in most/all provinces and territories: Diphtheria toxoid, Tetanus toxoid, Pertussis, Poliomyelitis, Haemophilus influenza type B, Measles, Mumps, Pneumococcus, Rubella, Hepatitis B Pediatric, Influenza, cholera vaccine (oral, inactivated) when used for prophylaxis against traveller's diarrhea & due to enterotoxigenic escherichia coli (ETEC); and those requiring special enhanced public access due to disease outbreaks: Meningococcus) I FEB / 02
Vaccines. which are part of a routine immunization program in most/all provinces and territories: Diptheria toxoid, Tetanus toxoid, Pertussis, Poliomyelitis, Haemophilus influenza type B, Measles, Mumps, Pneumococcus, Rubella, Hepatitis B Pediatric, Influenza, cholera vaccine (oral, inactivated) when used for prophylaxis against traveller's diarrhea & due to enterotoxigenic escherichia coli (ETEC); and those requiring special enhanced public access due to disease outbreaks: Meningococcus II FEB / 02
Valaciclovir or its saltsPDL I DEC / 13
Valdecoxib or its saltsPDL I DEC / 13
Valganciclovir or its salts or derivativesPDL I DEC / 13
Valproic acid or its saltsPDL

Including but not limited to Divalproex sodium

I DEC / 13
Valrubicin or its derivativesPDL I DEC / 13
Valsartan or its salts or derivativesPDL I DEC / 13
Vancomycin or its salts or derivativesPDL

including but not limited to Telavancin

I DEC / 13
Vandetanib or its salts or derivativesPDL I DEC / 13
Vardenafil or its saltsPDL I DEC / 13
Varenicline or its saltsPDL I DEC / 13
Varicella Zoster immune globulin I FEB / 02
Varicella vaccine (chicken pox) I FEB / 02
Vasopressin or its saltsPDL I DEC / 13
Vecuronium bromidePDL I DEC / 13
Vedaprofen or its salts or derivativesPDL I DEC / 13
VedolizumabPDL I MAR / 15
Vegetable tar except shampoos in concentrations of 5% or less III SEP / 98
Velaglucerase alfaPDL I DEC / 13
VelpatasvirPDL I AUG / 16
Vemurafenib or its salts or derivativesPDL I DEC / 13
Venetoclax or its saltsPDL I NOV / 16
Venlafaxine or its saltsPDL I DEC / 13
Verapamil or its saltsPDL I DEC / 13
Veratrum album or its alkaloids or their saltsPDL

for human use

I DEC / 13
Veratrum viride or its alkaloids or their saltsPDL

For human use

I DEC / 13
Vernakalant or its saltsPDL I APR / 17
Verteporfin or its salts or derivatives PDL I DEC / 13
VidarabinePDL I DEC / 13
Vigabatrin or its salts or derivativesPDL I DEC / 13
Vilanterol or its saltsPDL

Including but not limited to Vilaterol trifenatate

I DEC / 13
Vilazodone or its saltsPDL I AUG / 15
VinbarbitalC2 I JUN / 02
Vinblastine or its saltsPDL I DEC / 13
Vincristine or its saltsPDL I DEC / 13
Vindesine or its saltsPDL I DEC / 13
Vinorelbine or its saltsPDL I DEC / 13
VinylbitalC2 I JUN / 02
Viomycin or its salts or derivativesPDL I DEC / 13
Virginiamycin or its salts or derivativesPDL I DEC / 18
VismodegibPDL I DEC / 13
Vitamin APDL

in oral dosage forms containing more than 10,000 International Units of Vitamin A per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 10,000 International Units of Vitamin A for human use

I DEC / 13
Vitamin B12 with Intrinsic Factor ConcentratePDL I DEC / 13
Vitamin DPDL

For human use in oral dosage form containing more than 1,000 International Units of Vitamin D per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1,000 International Units of Vitamin D

I DEC / 13
Vitamin KPDL

except Vitamin K1 and Vitamin K2 sold (a) for external use in humans; or (b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or less For human use

I DEC / 13
Vitamins any parenterals not otherwise included in Schedule I II SEP / 98
Vitamins in injectable form for parenteral nutrition I JAN / 03
Vorapaxar or its saltsPDL I AUG / 16
VoriconazolePDL I DEC / 13
VorinostatPDL I DEC / 13
Vortioxetine or its saltsPDL

including but not limited to vortioxetine hydrobromide

I DEC / 14
Voxilaprevir or its saltsPDL I SEP / 17
Xanthinol nicotinatePDL I DEC / 13
Xylazine or its saltsPDL I DEC / 13
Xylometazoline and it salts in nasal preparations for pediatric use (0.05%) II SEP / 98
Xylometazoline and its salts in nasal preparations for adults (0.1%) U
Xylose II SEP / 98
Yellow Fever vaccine I FEB / 02
Yohimbine or its saltsPDL I DEC / 13
Zafirlukast or its saltsPDL I DEC / 13
Zalcitabine or its saltsPDL I DEC / 13
Zaleplon or its salts or its derivativesPDL I NOV / 18
Zanamivir or its salts or derivativesPDL I DEC / 13
ZeranolC3 I SEP / 98
ZidovudinePDL I DEC / 13
Zinc chloride in injectable form for parenteral nutrition I JAN / 03
Zinc sulfate in injectable form for parenteral nutrition I JAN / 03
Ziprasidone or its saltsPDL I MAY / 09
Zoledronic acid or its salts or derivativesPDL I DEC / 13
Zolmitriptan or its saltsPDL I DEC / 13
Zolpidem and any salts thereofTS I JAN / 03
Zomepirac or its saltsPDL I DEC / 13
Zopiclone or its saltsPDL I DEC / 13
ZucapsaicinPDL I DEC / 13
Zuclopenthixol or its salts or derivativesPDL

Including but not limited to zuclopenthixol hydrochloride

I DEC / 13
a - MethylthiofentanylN I JUN / 02
alpha1- proteinase inhibitor (human) I JAN / 06
nebivolol or its salts or derivativesPDL I DEC / 13
p-FluorofentanylN I JUN / 02

2020 result(s)

Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled